EurekaMag PDF full texts Chapter 48,286

Mazzetti, G.; Buonomini, G.; Signorini, L.F.; Santopadre, G.; Braccini, L.; Kircheis, F. 1953: Antituberculous vaccination in Toscana. Annali Della Sanita Pubblica 14(4): 887-968

Senderova, R.I. 1956: Antituberculous vaccination in adults. Problemy Tuberkuleza 34(4): 3-6

Weiss, D.W. 1958: Antituberculous vaccination in the guinea pig with non-living vaccines. American Review of Tuberculosis 77(4): 719-724

Foley, H.; Parrot, L. 1953: Antituberculous vaccination of children of all ages without preliminary tuberculin tests in Algeria. Archives de l'Institut Pasteur d'Algerie 31(4): 357-372

Dvoirin, M.S. 1959: Antituberculous vaccination of older children and adolescents in the Ukraine. Problemy Tuberkuleza 37(4): 10-15

Dvoirin, M.S. 1957: Antituberculous vaccination of older children and adolescents in a village. Sovetskaia Meditsina 21(4): 148-153

Domingo, P. 1953: Antituberculous vaccination with BCG, BCGization and BCG therapy in pediatric practice. Revista Cubana de Pediatria 25(3): 137-156

Kurylowicz, W. 1955: Antituberculous vaccination with freeze dried BCG vaccine. I. Properties of the dry BCG vaccine. Gruzlica 23(1): 1-11

Kurylowicz, W. 1955: Antituberculous vaccination with freeze dried BCG vaccine. II. Results of vaccination. Gruzlica 23(2): 73-80

Pham-Ngoc-Thach; Dang-Duc-Trach; Tang-Huu-Thanh; Nguyen-Thi-Hoi; Phan-Trinh 1961: Antituberculous vaccination with killed B.C.G. Medecine Dans le Monde 37: 31-35

Moutel, G.ég. 2017: Anticipating the role of the intensive care unit in healthcare and life trajectories. Annals of Translational Medicine 5(Suppl 4): S37

Weiss, D.W. 1959: Antituberculous vaccination with non-living vaccine; premise & prospects. Minerva Medica 50(30): 1082-1083

Condrea, P.; Franche, M.; Vita, A.; Teodorovici, G.; Duca, E.; Dragomir, C.; Lascu, N.; Mihu Popovici, V.; Segal, I.; Ene, M. 1954: Antitularemic living vaccine in therapy of tularemia. Igiena 2: 27-36

Zubova, O.V. 1959: Antitum or action of certain chlorethylamino and ethyleneimino derivatives of pyridine. Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 3(2): 34-38

Arakawa, M. 1964: Antitumor Action of 7 Membered Ring Compounds. Iv. Pharmacology of 2-Isonicotinoylhydrazino-5-Nitrosotropone N-Oxide (Rch-1003). Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 60: 471-490

Arakawa, M. 1964: Antitumor Action of 7-Membered Ring Compounds (1). Antitumor Action of Various 7-Membered Ring Compounds and 5-Nitrosotropolone (Rchlo8) Analogues. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 60: 52-61

Arakawa, M. 1964: Antitumor Action of 7-Membered Ring Compounds. (Ii) Antitumor Action of 2-Isonicotinoylhydrazino-5-Nitrosotropone (Rch-172) and its Related Compounds. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 60: 186-193

Ishizuka, M.; Takeuchi, T.; Nitta, K.; Koyama, G.; Hori, M.; Umezawa, H. 1964: Antitumor Activities of Formycin and Labilomycin. Journal of Antibiotics 17: 124-126

Yan, H.-M.; Han, M.-Z.; Han, J.-L.; Li, C.-W.; Liu, H.-Z. 2001: Antitumor Activities of KRN7000 in NS-1 Myeloma-Bearing Mice. Zhongguo Shi Yan Xue Ye Xue Za Zhi 9(4): 343-346

Vermel, E.M.; Kruglyak, S.A. 1965: Antitumor Activity of Gossypol in Experiments on Transplantable Tumors. Federation Proceedings. Translation Supplement; Selected Translations from Medical-Related Science 24: 106-108

Chernov, V.A.; Grushina, A.A.; Lytkina, L.T. 1964: Antitumor Activity of Phosphazine. Federation Proceedings. Translation Supplement; Selected Translations from Medical-Related Science 23: 39-42

Matsuura, S.; Shiratori, O.; Katagiri, K. 1964: Antitumor Activity of Showdomycin. Journal of Antibiotics 17: 234-237

Kravchenko, A.I. 1963: Antitumor Activity of some Derivatives of Bis(Beta-Chloroethyl)-Aminomethylazobenzene. Voprosy Onkologii 9: 18-22

Kahlos, K.; Kangas, L.; Hiltunen, R. 1986: Antitumor Activity of Triterpenes in Inonotus obliquus. Planta Medica 6: 554

Santosa, M.H.; Herzog, R.; Voelter, W. 1986: Antitumor Activity of the Hot Water Extract of Lobelia chinensis. Planta Medica 6: 555

Tognella, S.; Bignotti, G. 1964: ANTITUMOR CHEMOTHERAPY. Aggiornamenti clinicoterapeutici 5: 1-89

Gastaldi, A.; Dambrosio, F. 1964: Antitumor Chemotherapy in Ovarian Carcinoma. Annali di Ostetricia e Ginecologia 86: 407-456

Bianchi, F.; Cazzola, D. 1964: Antitumor Chemotherapy in the Treatment of Malignant Neoplasms of the Ovary. Quaderni di clinica ostetrica e ginecologica 19: 50-65

Shorin, V.A.; Rossolimo, O.K.; Stanislavskaya, M.S.; Blyumberg, N.A.; Filipposyan, S.T.; Lepeshkina, G.N. 1963: Antitumor effect of Antibiotic Olivomycin. Federation Proceedings. Translation Supplement; Selected Translations from Medical-Related Science 22: 1238-1240

Rossolimo, O.K.; Lepeshkina, G.N. 1964: Antitumor effect of Olivomycin Combined with Various Synthetic Cytotoxic Drugs. Federation Proceedings. Translation Supplement; Selected Translations from Medical-Related Science 23: 484-486

Volk, H.; Wilde, R.C.; Carabasi, R.A.; Bisel, H.F. 1965: Antitumor Efficacy of Norandrolone Phenpropionate Compared with Testosterone Propionate in Advanced Breast Cancer. Cancer 18: 651-655

Vodolazskaia, N.A. 1961: Antitumor action of various derivatives of sarcolysin and related compounds. Voprosy Onkologii 7(5): 77-84

Natile, G.; Coluccia, M. 2004: Antitumor active trans-platinum compounds. Metal Ions in Biological Systems 42: 209-250

Zhang, L.; Liu, W.-s.; Han, B.-q.; Peng, Y.-f.; Wang, D.-f. 2006: Antitumor activities of D-glucosamine and its derivatives. Journal of Zhejiang University. Science. B 7(8): 608-614

Unursaikhan, S.; Xu, X.; Zeng, F.; Zhang, L. 2006: Antitumor activities of O-sulfonated derivatives of (1-->3)-alpha-D-glucan from different Lentinus edodes. Bioscience Biotechnology and Biochemistry 70(1): 38-46

Matsuzaki, T.; Takagi, A.; Ikemura, H.; Matsuguchi, T.; Yokokura, T. 2004: Antitumor activity and action mechanisms of Lactobacillus casei through the regulation of immune responses. Biofactors 22(1-4): 63-66

Fukushima, M. 2006: Antitumor activity and function of S-1, a new oral tegafur-based formulation. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(Suppl 1): 19-26

Shan, B.E.; Hao, J.S.; Li, Q.X.; Tagawa, M. 2006: Antitumor activity and immune enhancement of murine interleukin-23 expressed in murine colon carcinoma cells. Cellular and Molecular Immunology 3(1): 47-52

Shah, N.T.; Miller, V.A. 2003: Antitumor activity and tolerability of gefitinib in patients with non-small-cell lung cancer treated in an expanded access program. Clinical Lung Cancer 5(3): 182-186

Gol'dberg, L.E.; Liashenko, V.A.; Stanislavskaia, M.S.; Muraveiskaia, V.S.; Kremer, V.E.; Filippos'ian, S.T.; Lepeshkina, G.N. 1962: Antitumor activity and toxicity of the antibiotic M-770. Antibiotiki 7: 971-975

Ribas, A.; Camacho, L.H.; Lopez-Berestein, G.; Pavlov, D.; Bulanhagui, C.A.; Millham, R.; Comin-Anduix, B.ña.; Reuben, J.M.; Seja, E.; Parker, C.A.; Sharma, A.; Glaspy, J.A.; Gomez-Navarro, J. 2005: Antitumor activity in melanoma and anti-self responses in a phase i trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 23(35): 8968-8977

Evans, J.S.; Musser, E.A.; Mengel, G.D.; Forsblad, K.R.; Hunter, J.H. 1961: Antitumor activity of 1-beta-D-arainofuranosylcytosine hydrochloride. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 106: 350-353

Gopal, M.; Shenoy, S.; Doddamani, L.S. 2003: Antitumor activity of 4-amino and 8-methyl-4-(3diethylamino propylamino)pyrimido[4',5':4,5]thieno (2,3-b) quinolines. Journal of Photochemistry and Photobiology. B Biology 72(1-3): 69-78

Evans, J.S.; Mengel, G.D. 1958: Antitumor activity of 5-bis(2-chloroethyl) amino uracil against sarcoma 180 and Ehrlich carcinoma. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 99(3): 620-622

Sato, A.; Ohtsuki, M.; Hata, M.; Kobayashi, E.; Murakami, T. 2006: Antitumor activity of IFN-lambda in murine tumor models. Journal of Immunology 176(12): 7686-7694

Samanta, S.; Pain, A.; Dutta, S.; Saxena, A.K.; Shanmugavel, M.; Pandita, R.M.; Qazi, G.N.; Sanyal, U. 2005: Antitumor activity of Nitronaphthal-NU, a novel mixed-function agent. Journal of Experimental Therapeutics and Oncology 5(1): 15-22

Ciardiello, F.; Bianco, R.; Caputo, R.; Caputo, R.; Damiano, V.; Troiani, T.; Melisi, D.; De Vita, F.; De Placido, S.; Bianco, A.R.; Tortora, G. 2004: Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 10(2): 784-793

Tuccillo, C.; Romano, M.; Troiani, T.; Martinelli, E.; Morgillo, F.; De Vita, F.; Bianco, R.; Fontanini, G.; Bianco, R.A.; Tortora, G.; Ciardiello, F. 2005: Antitumor activity of ZD6474, a vascular endothelial growth factor-2 and epidermal growth factor receptor small molecule tyrosine kinase inhibitor, in combination with SC-236, a cyclooxygenase-2 inhibitor. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(3): 1268-1276

Yaguchi, S.-i.; Fukui, Y.; Koshimizu, I.; Yoshimi, H.; Matsuno, T.; Gouda, H.; Hirono, S.; Yamazaki, K.; Yamori, T. 2006: Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor. Journal of the National Cancer Institute 98(8): 545-556

Su, C.-Q.; Wang, X.-H.; Chen, J.; Liu, Y.-J.; Wang, W.-G.; Li, L.-F.; Wu, M.-C.; Qian, Q.-J. 2006: Antitumor activity of an hTERT promoter-regulated tumor-selective oncolytic adenovirus in human hepatocellular carcinoma. World Journal of Gastroenterology 12(47): 7613-7620

Li, L.; Huang, Y.-H.; Li, Y.; Wang, F.-Q.; Shang, B.-Y.; Zhen, Y.-S. 2005: Antitumor activity of anti-type IV collagenase monoclonal antibody and its lidamycin conjugate against colon carcinoma. World Journal of Gastroenterology 11(29): 4478-4483

Dabrowska, K.; Opolski, A.; Wietrzyk, J.; Switala-Jelen, K.; Boratynski, J.; Nasulewicz, A.; Lipinska, L.; Chybicka, A.; Kujawa, M.; Zabel, M.; Dolinska-Krajewska, B.; Piasecki, E.; Weber-Dabrowska, B.; Rybka, J.; Salwa, J.; Wojdat, E.; Nowaczyk, M.; Gorski, A. 2004: Antitumor activity of bacteriophages in murine experimental cancer models caused possibly by inhibition of beta3 integrin signaling pathway. Acta Virologica 48(4): 241-248

Cheng, J.; Khin, K.T.; Davis, M.E. 2004: Antitumor activity of beta-cyclodextrin polymer-camptothecin conjugates. Molecular Pharmaceutics 1(3): 183-193

Smith, M.R. 2003: Antitumor activity of bisphosphonates. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 9(15): 5433-5434

Kumagi, K. 1962: Antitumor activity of carzinostatin. (Studies on the antibiotic substances from Actinomycetes. XLV). Journal of Antibiotics 15: 53-59

Sakurai, Y.; Sawatari, K. 1961: Antitumor activity of derivatives of nitrogen mustard containing a 2-chloroethyl group. Cancer ChemoTherapy Reports 13: 205-210

Hanauske, A-Rainer.; Oberschmidt, O.; Hanauske-Abel, H.; Lahn, M.M.; Eismann, U. 2007: Antitumor activity of enzastaurin (LY317615.HCl) against human cancer cell lines and freshly explanted tumors investigated in in-vitro [corrected] soft-agar cloning experiments. Investigational New Drugs 25(3): 205-210

Zhang, Y.; Banerjee, S.; Wang, Z.; Xu, H.; Zhang, L.; Mohammad, R.; Aboukameel, A.; Adsay, N.V.; Che, M.; Abbruzzese, J.L.; Majumdar, A.P.N.; Sarkar, F.H. 2006: Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factor-kappaB in pancreatic cancer. Cancer Research 66(2): 1025-1032

Wang, D.-H.; Weng, X.-C. 2006: Antitumor activity of extracts of Ganoderma lucidum and their protective effects on damaged HL-7702 cells induced by radiotherapy and chemotherapy. Zhongguo Zhong Yao Za Zhi 31(19): 1618-1622

Kuwahara, Y.; Hosoi, H.; Osone, S.; Kita, M.; Iehara, T.; Kuroda, H.; Sugimoto, T. 2004: Antitumor activity of gefitinib in malignant rhabdoid tumor cells in vitro and in vivo. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 10(17): 5940-5948

Zou, Y.; Fu, H.; Ghosh, S.; Farquhar, D.; Klostergaard, J. 2004: Antitumor activity of hydrophilic Paclitaxel copolymer prodrug using locoregional delivery in human orthotopic non-small cell lung cancer xenograft models. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 10(21): 7382-7391

Van Laar, E.S.; Izbicka, E.; Weitman, S.; Medina-Gundrum, L.; Macdonald, J.R.; Waters, S.J. 2004: Antitumor activity of irofulven against human ovarian cancer cell lines, human tumor colony-forming units, and xenografts. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 14(5): 824-831

Nakagawa, T.; Kawasaki, N.; Ma, Y.; Uemura, K.; Kawasaki, T. 2003: Antitumor activity of mannan-binding protein. Methods in Enzymology 363: 26-33

Yang, Y.-x.; Zhu, L.; He, X.; Bao, D.-y.; Bao, X. 2004: Antitumor activity of mitoxantrone-nanosphere against murine liver tumor H22. Sichuan da Xue Xue Bao. Yi Xue Ban 35(1): 68-70

Saulnier Sholler, G.L.; Kalkunte, S.; Greenlaw, C.; McCarten, K.; Forman, E. 2006: Antitumor activity of nifurtimox observed in a patient with neuroblastoma. Journal of Pediatric Hematology/Oncology 28(10): 693-695

Kim, S.-A.; Kim, Y.-C.; Kim, S.-W.; Lee, S.-H.; Min, J.-J.; Ahn, S.-G.; Yoon, J.-H. 2007: Antitumor activity of novel indirubin derivatives in rat tumor model. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 13(1): 253-259

Ferguson, D.; Rodriguez, L.E.; Palma, J.P.; Refici, M.; Jarvis, K.; O'Connor, J.; Sullivan, G.M.; Frost, D.; Marsh, K.; Bauch, J.; Zhang, H.; Lin, N.-H.; Rosenberg, S.; Sham, H.L.; Joseph, I.B.J.K. 2005: Antitumor activity of orally bioavailable farnesyltransferase inhibitor, ABT-100, is mediated by antiproliferative, proapoptotic, and antiangiogenic effects in xenograft models. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(8): 3045-3054

Mitsui, S.; Ogata, A.; Yanagie, H.; Kasano, H.; Hisa, T.; Yamase, T.; Eriguchi, M. 2006: Antitumor activity of polyoxomolybdate, [NH3Pri]6[Mo7O24].3H2O, against, human gastric cancer model. Biomedicine and PharmacoTherapy 60(7): 353-358

Carraz, G.; Gagnaire, D.; Dardas, A.; Rassat, A.; Beriel, H. 1963: Antitumor activity of products obtained by exposure of chlorpromazine to ultraviolet rays. Therapie 18: 171-176

Esumi, H.; Lu, J.; Kurashima, Y.; Hanaoka, T. 2004: Antitumor activity of pyrvinium pamoate, 6-(dimethylamino)-2-[2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl]-1-methyl-quinolinium pamoate salt, showing preferential cytotoxicity during glucose starvation. Cancer Science 95(8): 685-690

Seki, T.; Morimura, S.; Shigematsu, T.; Maeda, H.; Kida, K. 2004: Antitumor activity of rice-shochu post-distillation slurry and vinegar produced from the post-distillation slurry via oral administration in a mouse model. Biofactors 22(1-4): 103-105

Yano, J.; Hirabayashi, K.; Nakagawa, S.-I.; Yamaguchi, T.; Nogawa, M.; Kashimori, I.; Naito, H.; Kitagawa, H.; Ishiyama, K.; Ohgi, T.; Irimura, T. 2004: Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 10(22): 7721-7726

Luong, Q.T.; O'Kelly, J.; Braunstein, G.D.; Hershman, J.M.; Koeffler, H.P. 2006: Antitumor activity of suberoylanilide hydroxamic acid against thyroid cancer cell lines in vitro and in vivo. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12(18): 5570-5577

Andreani, A.; Burnelli, S.; Granaiola, M.; Leoni, A.; Locatelli, A.; Morigi, R.; Rambaldi, M.; Varoli, L.; Kunkel, M.W. 2006: Antitumor activity of substituted E-3-(3,4,5-trimethoxybenzylidene)-1,3-dihydroindol-2-ones1. Journal of Medicinal Chemistry 49(23): 6922-6924

Nosrati, M.; Li, S.; Bagheri, S.; Ginzinger, D.; Blackburn, E.H.; Debs, R.J.; Kashani-Sabet, M. 2004: Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 10(15): 4983-4990

Helfrich, B.A.; Raben, D.; Varella-Garcia, M.; Gustafson, D.; Chan, D.C.; Bemis, L.; Coldren, C.; Barón, A.; Zeng, C.; Franklin, W.A.; Hirsch, F.R.; Gazdar, A.; Minna, J.; Bunn, P.A. 2006: Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12(23): 7117-7125

Gullbo, J.; Wallinder, C.; Tullberg, M.; Lövborg, H.; Ehrsson, H.; Lewensohn, R.; Nygren, P.; Luthman, K.; Larsson, R. 2003: Antitumor activity of the novel melphalan containing tripeptide J3 (L-prolyl-L-melphalanyl-p-L-fluorophenylalanine ethyl ester): comparison with its m-L-sarcolysin analogue P2. Molecular Cancer Therapeutics 2(12): 1331-1339

Parrella, E.; Giannì, M.; Fratelli, M.; Barzago, M.M.; Raska, I.; Diomede, L.; Kurosaki, M.; Pisano, C.; Carminati, P.; Merlini, L.; Dallavalle, S.; Tavecchio, M.; Rochette-Egly, C.; Terao, M.; Garattini, E. 2006: Antitumor activity of the retinoid-related molecules (E)-3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid (ST1926) and 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) in F9 teratocarcinoma: Role of retinoic acid receptor gamma and retinoid-independent pathways. Molecular Pharmacology 70(3): 909-924

Shealy, Y.F.; Montgomery, J.A.; Laster, W.R. 1962: Antitumor activity of triazenoimidazoles. Biochemical Pharmacology 11: 674-676

Wang, Q.-C.; Feng, Z.-H.; Zhou, Y.-X.; Nie, Q.-H.; Bai, X.-F. 2004: Antitumor activity on murine mastocytoma induced by immunization with fusion of dendritic cells and P815 cells in mice. Zhonghua Gan Zang Bing Za Zhi 12(9): 559-560

Xiao, Z.; Bastow, K.F.; Vance, J.R.; Sidwell, R.S.; Wang, H.-K.; Chen, M.S.; Shi, Q.; Lee, K.-H. 2004: Antitumor agents. 234. Design, synthesis, and biological evaluation of novel 4beta-[(4' '-benzamido)-amino]-4'-o-demethyl-epipodophyllotoxin derivatives. Journal of Medicinal Chemistry 47(21): 5140-5148

Tietze, L.F.; Major, F.; Schuberth, I. 2006: Antitumor agents: development of highly potent glycosidic duocarmycin analogues for selective cancer therapy. Angewandte Chemie 45(39): 6574-6577

Zhou, J.-M.; Zhu, X.-F.; Liu, Z.-C.; Fu, L.-W.; Yang, X.-P.; Liang, Y.-J.; Pan, Q.-C. 2005: Antitumor and anti-angiogenic effects of manumycin on human hepatocellular carcinoma HepG2 xenografts in nude mice. Ai Zheng 24(8): 935-939

Imagawa, Y.; Satake, K.; Kato, Y.; Tahara, H.; Tsukuda, M. 2004: Antitumor and antiangiogenic effects of interleukin 12 gene therapy in murine head and neck carcinoma model. Auris Nasus Larynx 31(3): 239-245

Li, Y.; Kucuk, O.; Hussain, M.; Abrams, J.; Cher, M.L.; Sarkar, F.H. 2006: Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer. Cancer Research 66(9): 4816-4825

Kimura, Y.; Sumiyoshi, M.; Suzuki, T.; Sakanaka, M. 2006: Antitumor and antimetastatic activity of a novel water-soluble low molecular weight beta-1, 3-D-glucan (branch beta-1,6) isolated from Aureobasidium pullulans 1A1 strain black yeast. Anticancer Research 26(6b): 4131-4141

Artym, J. 2006: Antitumor and chemopreventive activity of lactoferrin. Postepy Higieny i Medycyny Doswiadczalnej 60: 352-369

Liu, H.-S.; Pan, C.-E.; Yang, W.; Liu, X.-M. 2003: Antitumor and immunomodulatory activity of resveratrol on experimentally implanted tumor of H22 in Balb/c mice. World Journal of Gastroenterology 9(7): 1474-1476

Cao, Y.; Xia, Q.-H.; Meng, H.; Zhong, A.-P. 2005: Antitumor and synergistic effect of Chinese medicine "bushen huayu jiedu recipe" and chemotherapy on transplanted animal hepatocarcinoma. World Journal of Gastroenterology 11(33): 5218-5220

Hata, T. 1959: Antitumor antibiotics from streptomyces. Acta - Unio Internationalis Contra Cancrum 15(Suppl 1): 123-128

Galm, U.; Hager, M.H.; Van Lanen, S.G.; Ju, J.; Thorson, J.S.; Shen, B. 2005: Antitumor antibiotics: bleomycin, enediynes, and mitomycin. Chemical Reviews 105(2): 739-758

Clynes, R. 2006: Antitumor antibodies in the treatment of cancer: Fc receptors link opsonic antibody with cellular immunity. Hematology/Oncology Clinics of North America 20(3): 585-612

Krieg, A.M. 2004: Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides. Current Oncology Reports 6(2): 88-95

Goldman, S.C. 2003: Rasburicase: potential role in managing tumor lysis in patients with hematological malignancies. Expert Review of Anticancer Therapy 3(4): 429-433

Mortimer, C.G.; Wells, G.; Crochard, J.-P.; Stone, E.L.; Bradshaw, T.D.; Stevens, M.F.G.; Westwell, A.D. 2006: Antitumor benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines. Journal of Medicinal Chemistry 49(1): 179-185

O'Brien, S.E.; Browne, H.L.; Bradshaw, T.D.; Westwell, A.D.; Stevens, M.F.; Laughton, C.A. 2003: Antitumor benzothiazoles. Frontier molecular orbital analysis predicts bioactivation of 2-(4-aminophenyl)benzothiazoles to reactive intermediates by cytochrome P4501A1. Organic and Biomolecular Chemistry 1(3): 493-497

Asche, C.; Demeunynck, M. 2007: Antitumor carbazoles. Anti-Cancer Agents in Medicinal Chemistry 7(2): 247-267

Aimová, D.; Stiborová, M. 2005: Antitumor drug ellipticine inhibits the activities of rat hepatic cytochromes P450. Biomedical Papers of the Medical Faculty of the University Palacky Olomouc Czechoslovakia 149(2): 437-440

Liu, Z-Yang.; Wang, Z-Guang.; Liu, X-Jing.; Tian, H-Mei.; Surapol; Na, D-Ya.; Zhang, Y-Fei.; Zhang, W. 2004: Antitumor effect and apoptosis induction in human cancer cell lines by BRM-SJS. Ai Zheng 23(11): 1386-1389

Huang, H.; Xie, B.-F.; Zhu, X.-F.; Feng, G.-K.; Zhou, J.-M.; Wang, Y.; Wu, H.-Q.; Huang, Z.-S.; Gu, L.-Q.; Liu, Z.-C. 2005: Antitumor effect and mechanism of shikonin derivative SYUNZ-7. Ai Zheng 24(12): 1453-1458

Heim, M.; Sharifi, M.; Hilger, R.A.; Scheulen, M.E.; Seeber, S.; Strumberg, D. 2003: Antitumor effect and potentiation or reduction in cytotoxic drug activity in human colon carcinoma cells by the Raf kinase inhibitor (RKI) BAY 43-9006. International Journal of Clinical Pharmacology and Therapeutics 41(12): 616-617

Komai, T.; Higurashi, H.; Abe, M.; Mizuno, D. 1957: Antitumor effect of 2-substituted benzimidazole on solid type of Ehrlich ascites tumor. Japanese Journal of Medical Science and Biology 10(6): 455-459

Zhu, B.-D.; Yuan, S.-J.; Zhao, Q.-C.; Li, X.; Li, Y.; Lu, Q.-Y. 2005: Antitumor effect of Gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, combined with cytotoxic agent on murine hepatocellular carcinoma. World Journal of Gastroenterology 11(9): 1382-1386

Oshikawa, T.; Okamoto, M.; Tano, T.; Sasai, A.; Kan, S.; Moriya, Y.; Ryoma, Y.; Saito, M.; Akira, S.; Sato, M. 2006: Antitumor effect of OK-432-derived DNA: one of the active constituents of OK-432, a streptococcal immunotherapeutic agent. Journal of ImmunoTherapy 29(2): 143-150

Aranowska, K.; Graczyk, J.; Checińska, L.; Pakulska, W.; Ochock, J. 2006: Antitumor effect of Pt(II) amine phosphonate complexes on sarcoma sa-180 in mice. Crystal structure of cis-dichlorobis(diethyl-4-pyridylmethylphosphonate-kappaN)platinum(II) hydrate, cis-[PtCl2(4-pmpe)2].H20. Die Pharmazie 61(5): 457-460

Roomi, M.W.; Ivanov, V.; Kalinovsky, T.; Niedzwiecki, A.; Rath, M. 2005: Antitumor effect of a combination of lysine, proline, arginine, ascorbic acid, and green tea extract on pancreatic cancer cell line MIA PaCa-2. International Journal of Gastrointestinal Cancer 35(2): 97-102

Horiguchi, Y.; Kuroda, K.; Nakashima, J.; Murai, M.; Umezawa, K. 2003: Antitumor effect of a novel nuclear factor-kappa B activation inhibitor in bladder cancer cells. Expert Review of Anticancer Therapy 3(6): 793-798

Xu, H.; Yang, X.; Yang, J.; Qi, W.; Liu, C.; Yang, Y. 2003: Antitumor effect of alcohol extract from Sesamum indicum flower on S180 and H22 experimental tumor. Zhong Yao Cai 26(4): 272-273

Vodolazskaia, N.A.; Novikova, M.A.; Shkodinskaia, E.N.; Vasina, O.S.; Berlin, A.I.; Larionov, L.F. 1957: Antitumor effect of certain sarkolizin derivatives; [dl-p-di-(2-chloroethyl) aminophenylalanine. Biulleten' Eksperimental'noi Biologii i Meditsiny 44(11): 76-81

Nakamura, K.; Yoshikawa, N.; Yamaguchi, Y.; Kagota, S.; Shinozuka, K.; Kunitomo, M. 2006: Antitumor effect of cordycepin (3'-deoxyadenosine) on mouse melanoma and lung carcinoma cells involves adenosine A3 receptor stimulation. Anticancer Research 26(1a): 43-47

Xiang, S.-L.; Xiao, X.-L.; Ling, H.; Liao, Q.-J.; Zhou, X.-T.; Dong, L.; Su, Q. 2005: Antitumor effect of diallyl disulfide on human gastric cancer MGC803 cells xenograft in nude mice. Ai Zheng 24(8): 940-944

Shakuto, S.; Noguchi, K.; Bissery, M.-C. 2005: Antitumor effect of docetaxel against human endometrial tumor cell lines. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(10): 1437-1442

Shakuto, S.; Fujita, F.; Fujita, M. 2006: Antitumor effect of docetaxel against human esophagus tumor cell lines and tumor xenografts in nude mice. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(3): 337-343

Zhou, L.; Yan, M.-X.; Yao, M.; Feng, Y.-J. 2005: Antitumor effect of endothelial progenitor cells with TRAIL gene transfection on ovarian carcinoma xenografts in nude mice. Ai Zheng 24(11): 1312-1316

Mita, Y.; Ajiki, T.; Kamigaki, T.; Okazaki, T.; Hori, H.; Horiuchi, H.; Hirata, K.; Fujita, T.; Fujimori, T.; Kuroda, Y. 2007: Antitumor effect of gemcitabine on orthotopically inoculated human gallbladder cancer cells in nude mice. Annals of Surgical Oncology 14(4): 1374-1380

Du, J.; Ran, Y.; Lin, Z.; Zheng, C.; Wei, H.; Wang, X.; Zhou, L.; Ren, Y. 2003: Antitumor effect of gene therapy with recombinant adenovirus-mediated human interleukin-2 gene transfer and its mechanism. Sichuan da Xue Xue Bao. Yi Xue Ban 34(1): 12-15

Zhang, H.; Zheng, S.-S.; Jiang, G.-P.; Wu, L.-H.; Zhu, F.; Yang, Z.-L. 2004: Antitumor effect of immunization with fusion of dendritic cells and hepatocellular carcinoma cells in mice. Hepatobiliary and Pancreatic Diseases International: Hbpd Int 3(2): 235-240

Zhang, H.; Zheng, S.-s.; Jiang, G.-p.; Zhou, L.; Xie, H.-y. 2004: Antitumor effect of immunizations with fusions of dendritic and hepatocellular carcinoma cells in mice. Zhonghua Gan Zang Bing Za Zhi 12(11): 648-651

Murakami, T.; Tokunaga, N.; Waku, T.; Gomi, S.; Kagawa, S.; Tanaka, N.; Fujiwara, T. 2004: Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 10(11): 3871-3880

Shin, J.Y.; Lee, S.K.; Kang, C.D.; Chung, J.S.; Lee, E.Y.; Seo, S.Y.; Lee, S.Y.; Baek, S.Y.; Kim, B.S.; Kim, J.B.; Yoon, S. 2003: Antitumor effect of intratumoral administration of dendritic cell combination with vincristine chemotherapy in a murine fibrosarcoma model. Histology and Histopathology 18(2): 435-447

Ostrovskaia, L.A.; Budnik, M.I.; Korman, D.B.; Bliukhterova, N.V.; Fomina, M.M.; Rykova, V.A.; Burlakova, E.B. 2003: Antitumor effect of joint action of low intensity electromagnetic fields and ultra low doses of doxorubicin. Radiatsionnaia Biologiia Radioecologiia 43(3): 351-354

Liu, X.Y.; Zhen, Y.S. 2001: Antitumor effect of lidamycin-containing monoclonal antibody immunoconjugate with downsized-molecule. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 23(6): 563-567

Wada, S.; Tazawa, K.; Furuta, I.; Nagae, H. 2003: Antitumor effect of new local hyperthermia using dextran magnetite complex in hamster tongue carcinoma. Oral Diseases 9(4): 218-223

Roomi, M.W.; Ivanov, V.; Kalinovsky, T.; Niedzwiecki, A.; Rath, M. 2005: Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1. Oncology Reports 13(2): 253-257

Nishibori, A. 1957: Antitumor effect of pluramycin a on experimental animal tumors; studies on antitumor products of Streptomyces. Ii. Journal of Antibiotics 10(5): 213-218

Takeuchi, T.; Nitta, K.; Umezawa, H. 1956: Antitumor effect of pluramycin crude powder on Ehrlich carcinoma of mice. Studies on antitumor substances produced by microorganisms. X. Journal of Antibiotics 9(1): 22-30

Li, X.-H.; Tang, L.; Liu, D.; Sun, H.-M.; Zhou, C.-C.; Tan, L.-S.; Wang, L.-P.; Zhang, P.-D.; Zhang, S.-Q. 2006: Antitumor effect of recombinant T7 phage vaccine expressing xenogenic vascular endothelial growth factor on Lewis lung cancer in mice. Ai Zheng 25(10): 1221-1226

Niu, T.; Liu, T.; Jia, Y.-Q.; Liu, J.-Y.; Wu, Y.; Hu, B.; Tian, L.; Yang, L.; Kan, B.; Wei, Y.-Q. 2005: Antitumor effect of recombinant Xenopus laevis vascular endothelial growth factor (VEGF) as a vaccine combined with adriamycin on EL4 lymphoma in mice. Sichuan da Xue Xue Bao. Yi Xue Ban 36(5): 661

Hikosaka, S.; Hara, I.; Miyake, H.; Hara, S.; Kamidono, S. 2004: Antitumor effect of simultaneous transfer of interleukin-12 and interleukin-18 genes and its mechanism in a mouse bladder cancer model. International Journal of Urology: Official Journal of the Japanese Urological Association 11(8): 647-652

Mishima, S.; Matsumoto, K.; Futamura, Y.; Araki, Y.; Ito, T.; Tanaka, T.; Iinuma, M.; Nozawa, Y.; Akao, Y. 2003: Antitumor effect of stilbenoids from Vateria indica against allografted sarcoma S-180 in animal model. Journal of Experimental Therapeutics and Oncology 3(5): 283-288

Kimura, K.; Sawada, T.; Komatsu, M.; Inoue, M.; Muguruma, K.; Nishihara, T.; Yamashita, Y.; Yamada, N.; Ohira, M.; Hirakawa, K. 2006: Antitumor effect of trastuzumab for pancreatic cancer with high HER-2 expression and enhancement of effect by combined therapy with gemcitabine. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12(16): 4925-4932

Blishchenko, E.Y.; Sazonova, O.V.; Kalinina, O.A.; Moiseeva, E.V.; Vass, A.A.; Karelin, A.A.; Ivanov, V.T. 2005: Antitumor effect of valorphin in vitro and in vivo: combined action with cytostatic drugs. Cancer Biology and Therapy 4(1): 118-124

Ciria, H.C.; Quevedo, M.S.; Cabrales, L.B.; Bruzón, R.P.; Salas, M.F.; Pena, O.G.; González, T.R.; López, D.S.; Flores, J.M. 2004: Antitumor effectiveness of different amounts of electrical charge in Ehrlich and fibrosarcoma Sa-37 tumors. Bmc Cancer 4: 87

Fujiwara, K. 2006: Antitumor effects and clinical problems of transcatheter intraarterial infusion for uterine cervical cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(9): 1236-1240

Chen, P.; Cameron, R.; Wang, J.; Vallis, K.A.; Reilly, R.M. 2003: Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 44(9): 1469-1478

Wu, D.-H.; Liu, L.; Chen, L.-H. 2005: Antitumor effects and radiosensitization of cytosine deaminase and thymidine kinase fusion suicide gene on colorectal carcinoma cells. World Journal of Gastroenterology 11(20): 3051-3055

Ukawa, Y.; Ito, H.; Hisamatsu, M. 2000: Antitumor effects of (1-->3)-beta-D-glucan and (1-->6)-beta-D-glucan purified from newly cultivated mushroom, Hatakeshimeji (Lyophyllum decastes Sing.). Journal of Bioscience and Bioengineering 90(1): 98-104

Saiko, P.; Horvath, Z.; Murias, M.; Handler, N.; Jaeger, W.; Erker, T.; Fritzer-Szekeres, M.; Szekeres, T. 2006: Antitumor effects of 3,3',4,4',5,5'-hexahydroxystilbene in HL-60 human promyelocytic leukemia cells. Nucleosides Nucleotides and Nucleic Acids 25(9-11): 1013-1017

Yamashita, Y.; Ishiguro, Y.; Sano, D.; Kimura, M.; Fujita, K.; Yoshida, T.; Horiuchi, C.; Taguchi, T.; Matsuda, H.; Mikami, Y.; Tsukuda, M. 2007: Antitumor effects of Nafamostat mesilate on head and neck squamous cell carcinoma. Auris Nasus Larynx 34(4): 487-491

Ciardiello, F.; Caputo, R.; Damiano, V.; Caputo, R.; Troiani, T.; Vitagliano, D.; Carlomagno, F.; Veneziani, B.M.; Fontanini, G.; Bianco, A.R.; Tortora, G. 2003: Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 9(4): 1546-1556

Ran, S.; He, J.; Huang, X.; Soares, M.; Scothorn, D.; Thorpe, P.E. 2005: Antitumor effects of a monoclonal antibody that binds anionic phospholipids on the surface of tumor blood vessels in mice. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(4): 1551-1562

Kulp, S.K.; Chen, C.-S.; Wang, D.-S.; Chen, C.-Y.; Chen, C.-S. 2006: Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12(17): 5199-5206

Kim, K.S.; Park, Y.S. 2005: Antitumor effects of angiostatin K1-3 and endostatin genes coadministered by the hydrodynamics-based transfection method. Oncology Research 15(7-8): 343-350

Zhang, J.; Ji, J.; Ji, Y.-B.; Yuan, F.; Liu, B.-Y.; Zhu, Z.-G.; Lin, Y.-Z. 2005: Antitumor effects of chemotherapeutic drugs on fresh human gastric cancer cells and their relationships to expressions of P-glycoprotein and glutathione S transferase-pi. Ai Zheng 24(4): 432-437

Daubiné, F.; Le Gall, C.él.; Gasser, J.; Green, J.; Clézardin, P. 2007: Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis. Journal of the National Cancer Institute 99(4): 322-330

Yang, X.-J.; Huang, J.-A.; Lei, W.; Zhu, Y.-B.; Zhang, X.-G. 2006: Antitumor effects of cocultured dendritic cells and cytokine-induced killer cells on lung cancer in vitro and in vivo. Ai Zheng 25(11): 1329-1333

Sun, C.-j.; Xie, L. 2003: Antitumor effects of electrothermal and electrochemical therapy on mice with sarcoma180. Zhonghua Kou Qiang Yi Xue Za Zhi 38(5): 351-354

Niwa, H.; Wentzel, A.L.; Li, M.; Gooding, W.E.; Lui, V.W.Y.; Grandis, J.R. 2003: Antitumor effects of epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 9(13): 5028-5035

Preston, F.W.; Jackson, E.J.; Henegar, G.C.; Schrek, R. 1958: Antitumor effects of homologous immune serum, immune lymphocytes and nitrogen mustard against a rat lymphoma. Surgical Forum 9: 583-587

Chen, J.-X.; Gao, Y.; Liu, J.-W.; Tian, Y.-X.; Zhao, J.; Cui, X.-Y. 2005: Antitumor effects of human ribonuclease inhibitor gene transfected on B16 melanoma cells. International Journal of Biochemistry and Cell Biology 37(6): 1219-1231

Mei, K.; Tian, L.; Wei, Y.-Q.; Li, J.; Wen, Y.-J.; Kan, B.; Deng, H.-X. 2005: Antitumor effects of interferon-gamma-inducible protein 10 combined with gemcitabine. Ai Zheng 24(4): 397-402

Ebina, T. 2005: Antitumor effects of intratumoral injection of Basidiomycetes preparations. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 32(11): 1654-1656

Liu, X.; Zhen, Y. 2002: Antitumor effects of monoclonal antibody Fab' fragment-containing immunoconjugates. Chinese Medical Sciences Journal 17(1): 1-6

Mao, J.-S.; Wang, K.-W.; Zheng, S.; Pan, Y.-J. 2006: Antitumor effects of novel triterpene from Celastrus hypoleucus on human colorectal cancer cell line RKO in vitro. Zhongguo Zhong Yao Za Zhi 31(17): 1450-1453

Hayashi, N.; Nakamori, S.; Hiraoka, N.; Tsujie, M.; Xundi, X.; Takano, T.; Amino, N.; Sakon, M.; Monden, M. 2004: Antitumor effects of peroxisome proliferator activate receptor gamma ligands on anaplastic thyroid carcinoma. International Journal of Oncology 24(1): 89-95

Knapp, D.W.; Glickman, N.W.; Mohammed, S.I.; DeNicola, D.B.; Widmer, W.R.; Bonney, P.L.; DeGortari, A.E. 2002: Antitumor effects of piroxicam in spontaneous canine invasive urinary bladder cancer, a relevant model of human invasive bladder cancer. Advances in Experimental Medicine and Biology 507: 377-380

Hou, J.-M.; Liu, J.-Y.; Yang, L.; Zhao, X.; Tian, L.; Lei, S.; Mao, Y.-Q.; Wen, Y.-J.; Wei, Y.-Q. 2005: Antitumor effects of recombinant quail vascular endothelial growth factor receptor 2, as a vaccine, combined with cisplatin on LL/2 tumor model in mice. Ai Zheng 24(4): 391-396

Wang, A.-X.; Li, S.; Ding, X.-Q.; Chen, Y.; Chen, D. 2005: Antitumor effects of ring-closed and ring-opened hydroxycamptothecin on oral squamous carcinoma cell line Tca8113. Ai Zheng 24(8): 970-974

Ozawa, T.; Gryaznov, S.M.; Hu, L.J.; Pongracz, K.; Santos, R.A.; Bollen, A.W.; Lamborn, K.R.; Deen, D.F. 2004: Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts. Neuro-Oncology 6(3): 218-226

Ono, T.; Harada, M.; Yamada, A.; Tanaka, M.; Takao, Y.; Tanaka, Y.; Mine, T.; Sakamoto, K.; Nakashima, T.; Itoh, K. 2006: Antitumor effects of systemic and local immunization with a CTL-directed peptide in combination with a local injection of OK-432. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12(4): 1325-1332

Ng, S.S.W.; MacPherson, G.R.; Gütschow, M.; Eger, K.; Figg, W.D. 2004: Antitumor effects of thalidomide analogs in human prostate cancer xenografts implanted in immunodeficient mice. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 10(12 Part 1): 4192-4197

Li, Q.; Li, L.; Li, Z.; Gong, F.; Feng, W.; Jiang, X.; Xiong, P. 2002: Antitumor effects of the fibroblasts transfected TNF-alpha gene and its mutants. Journal of Huazhong University of Science and Technology. Medical Sciences 22(2): 92-95

Fengqiang, W.; Boyang, S.; Yongsu, Z. 2004: Antitumor effects of the molecule-downsized immunoconjugate composed of lidamycin and Fab' fragment of monoclonal antibody directed against type IV collagenase. Science in China. Series C Life Sciences 47(1): 66-73

Poma, P.; Notarbartolo, M.; Labbozzetta, M.; Sanguedolce, R.; Alaimo, A.; Carina, V.; Maurici, A.; Cusimano, A.; Cervello, M.; D'Alessandro, N. 2006: Antitumor effects of the novel NF-kappaB inhibitor dehydroxymethyl-epoxyquinomicin on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production. International Journal of Oncology 28(4): 923-930

Liu, B.-Y.; Chen, X.-H.; Gu, Q.-L.; Li, J.-F.; Yin, H.-R.; Zhu, Z.-G.; Lin, Y.-Z. 2004: Antitumor effects of vaccine consisting of dendritic cells pulsed with tumor RNA from gastric cancer. World Journal of Gastroenterology 10(5): 630-633

Chiyo, M.; Shimozato, O.; Iizasa, T.; Fujisawa, T.; Tagawa, M. 2004: Antitumor effects produced by transduction of dendritic cells-derived heterodimeric cytokine genes in murine colon carcinoma cells. Anticancer Research 24(6): 3763-3767

Thomas, A.N.; Gordan, G.S.; Goldmanl; Lowe, R. 1962: Antitumor efficacy of 2alpha-methyl dihydrotestosterone propionate in advanced breast cancer. Cancer 15: 176-178

Yi, C.; Guo, Z-ying.; Huang, Y.; Wang, H-yi.; Wang, S-ren. 2005: Antitumor efficacy of CD/5-FC suicide gene therapy system mediated by Bifidobacterium infantis against melanoma. Sichuan da Xue Xue Bao. Yi Xue Ban 36(2): 165-168

Buchsbaum, D.J.; Zhou, T.; Grizzle, W.E.; Oliver, P.G.; Hammond, C.J.; Zhang, S.; Carpenter, M.; LoBuglio, A.F. 2003: Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 9(10 Part 1): 3731-3741

Cassetti, M.Cristina.; McElhiney, S.P.; Shahabi, V.; Pullen, J.K.; Le Poole, I.Caroline.; Eiben, G.L.; Smith, L.R.; Kast, W.Martin. 2004: Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes. Vaccine 22(3-4): 520-527

DiJoseph, J.F.; Dougher, M.M.; Kalyandrug, L.B.; Armellino, D.C.; Boghaert, E.R.; Hamann, P.R.; Moran, J.K.; Damle, N.K. 2006: Antitumor efficacy of a combination of CMC-544 (inotuzumab ozogamicin), a CD22-targeted cytotoxic immunoconjugate of calicheamicin, and rituximab against non-Hodgkin's B-cell lymphoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12(1): 242-249

Zupi, G.; Scarsella, M.; Semple, S.C.; Mottolese, M.; Natali, P.G.; Leonetti, C. 2005: Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(5): 1990-1998

Blanquicett, C.; Saif, M.W.; Buchsbaum, D.J.; Eloubeidi, M.; Vickers, S.M.; Chhieng, D.C.; Carpenter, M.D.; Sellers, J.C.; Russo, S.; Diasio, R.B.; Johnson, M.R. 2005: Antitumor efficacy of capecitabine and celecoxib in irradiated and lead-shielded, contralateral human BxPC-3 pancreatic cancer xenografts: clinical implications of abscopal effects. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(24 Part 1): 8773-8781

Ciomei, M.; Croci, V.; Ciavolella, A.; Ballinari, D.; Pesenti, E. 2006: Antitumor efficacy of edotecarin as a single agent and in combination with chemotherapy agents in a xenograft model. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12(9): 2856-2861

Deng, Y.-J.; Xia, J.-C.; Zhou, J.; Wang, Q.-J.; Zhang, P.-Y.; Zhang, L.-J.; Rong, T.-H. 2007: Antitumor efficacy of fusion cells from esophageal carcinoma cells and dendritic cells as a vaccine in vitro. Ai Zheng 26(2): 137-141

Huang, Y.-H.; Shang, B.-Y.; Zhen, Y.-S. 2005: Antitumor efficacy of lidamycin on hepatoma and active moiety of its molecule. World Journal of Gastroenterology 11(26): 3980-3984

Hu, Y.; Bebb, G.; Tan, S.; Ng, R.; Yan, H.; Sartor, J.R.; Mayer, L.D.; Bally, M.B. 2004: Antitumor efficacy of oblimersen Bcl-2 antisense oligonucleotide alone and in combination with vinorelbine in xenograft models of human non-small cell lung cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 10(22): 7662-7670

Tao, G.-S.; Hu, J.-Y.; Liu, F.-Y. 2004: Antitumor immune response to cervix carcinoma in mice induced by HPV16 E6 DNA vaccines. Zhong Nan da Xue Xue Bao. Yi Xue Ban 29(1): 11-14

Liu, C.-l.; Dou, K.-f.; Zang, X.-x.; Zhu, B.-f.; Chen, S.-m. 2004: Antitumor immune responses induced by gene transfer of 4-1BBL into hepatocellular carcinoma Hepa1-6 in vitro. Zhonghua Wai Ke Za Zhi 42(9): 554-558

Catros-Quemener, V.ér.; Bouet, F.ço.; Genetet, N.ël. 2003: Antitumor immunity and cellular cancer therapies. Medecine Sciences: M/S 19(1): 43-53

Evans, C.A.; Gorman, L.R.; Ito, Y.; Weiser, R.S. 1962: Antitumor immunity in the Shope papilloma-carcinoma complex of rabbits. I. Papilloma regression induced by homologous and autologous tissue vaccines. Journal of the National Cancer Institute 29: 277-285

Wang, X.-P.; Liu, G.-Z.; Song, A.-L.; Li, H.-Y.; Liu, Y. 2004: Antitumor immunity induced by DNA vaccine encoding alpha-fetoprotein/heat shock protein 70. World Journal of Gastroenterology 10(21): 3197-3200

Fil'chakov, F.V.; Grinevich, I.A.; Shumilina, E.S.; Shved, V.V. 2005: Antitumor immunity transfer by a factor isolated from lymphocytes of tumor bearer. Voprosy Onkologii 51(6): 712-716

Herold-Mende, C.; Karcher, J.; Dyckhoff, G.; Schirrmacher, V. 2005: Antitumor immunization of head and neck squamous cell carcinoma patients with a virus-modified autologous tumor cell vaccine. Advances in Oto-Rhino-Laryngology 62: 173-183

Zhang, J-Kun.; Li, J.; Zhang, J.; Chen, H-Bin.; Chen, S-Biao. 2003: Antitumor immunopreventive and immunotherapeutic effect in mice induced by hybrid vaccine of dendritic cells and hepatocarcinoma in vivo. World Journal of Gastroenterology 9(3): 479-484

Tian, G.; Yi, J-Lin.; Xiong, P. 2004: Antitumor immunopreventive effect in mice induced by DNA vaccine encoding a fusion protein of alpha-fetoprotein and CTLA4. World Journal of Gastroenterology 10(2): 200-204

Malinka, W.ła.; Kaczmarz, M.; Redzicka, A. 2004: Antitumor in vitro evaluation of certain derivatives of pyrido-1,2-thiazines. Acta Poloniae Pharmaceutica 61 Suppl: 100-102

Du, Q.-Y.; Wang, X.-B.; Chen, X.-J.; Zheng, W.; Wang, S.-Q. 2003: Antitumor mechanism of antisense cantide targeting human telomerase reverse transcriptase. World Journal of Gastroenterology 9(9): 2030-2035

Padhye, S.; Afrasiabi, Z.; Sinn, E.; Fok, J.; Mehta, K.; Rath, N. 2005: Antitumor metallothiosemicarbazonates: structure and antitumor activity of palladium complex of phenanthrenequinone thiosemicarbazone. Inorganic Chemistry 44(5): 1154-1156

Behrens, F.; Zollner, T.; Moeller, B.; Kaltwasser, J.P.; Kaufmann, R.; Ochsendorf, F.R. 2003: Antitumor necrosis factor monoclonal antibody therapy in a woman with severe Adamantiades-Behçet's disease. Advances in Experimental Medicine and Biology 528: 561-562

Byeon, J-Sik.; Choi, E.Kwang.; Heo, N.Yun.; Hong, S.Chan.; Myung, S-Jae.; Yang, S-Kyun.; Kim, J-Ho.; Song, J-Kwan.; Yoo, B.; Yu, C.Sik. 2007: Antitumor necrosis factor-alpha therapy for early postoperative recurrence of gastrointestinal Behçet's disease: report of a case. Diseases of the Colon and Rectum 50(5): 672-676

Montané, E.; Sallés, M.; Barriocanal, A.; Riera, E.; Costa, J.; Tena, X. 2007: Antitumor necrosis factor-induced neutropenia: a case report with double positive rechallenges. Clinical Rheumatology 26(9): 1527-1529

Wietrzyk, J.; Chodyński, Mł.; Fitak, H.; Wojdat, E.; Kutner, A.; Opolski, A. 2007: Antitumor properties of diastereomeric and geometric analogs of vitamin D3. Anti-Cancer Drugs 18(4): 447-457

Schönthal, A.H. 2006: Antitumor properties of dimethyl-celecoxib, a derivative of celecoxib that does not inhibit cyclooxygenase-2: implications for glioma therapy. Neurosurgical Focus 20(4): E21

Bekker, Z.E. 1961: Antitumor properties of mycelial extracts of certain fungi. Antibiotiki 6: 488-492

Harada, H.; Kizaka-Kondoh, S.; Hiraoka, M. 2006: Antitumor protein therapy; application of the protein transduction domain to the development of a protein drug for cancer treatment. Breast Cancer 13(1): 16-26

Zhang, S.; Li, W.-F.; Zhang, H.-J.; Wang, Q. 2004: Antitumor reactivity of splenocytes primed in vivo with dendritic-cell-based vaccine and secondarily activated with a cocktail of cytokines in vitro. Experimental Oncology 26(3): 243-245

Guan, G.; Jin, N.; Mi, Z.; Li, X.; Lian, H.; Jin, C.; Sun, L.; Wen, L. 2005: Antitumor research on human laryngeal carcinoma with combined application of VP3 gene, IL-18 gene and HN gene. Lin Chuang Er Bi Yan Hou Ke Za Zhi 19(15): 704-706

Mi, Z.-Q.; Jin, N.-Y.; Sun, Y.-C.; Li, X.; Lian, H.; Li, J.; Guan, G.-F. 2004: Antitumor research on mouse melanoma with combined application of Newcastle disease virus and its HN gene. Ai Zheng 23(8): 910-913

Kazmin, S.D.; Todor, I.N.; Chekhun, V.F. 2005: Antitumor resistance activation in mice: can the immunological memory cells enhance resistance?. Journal of Experimental and Clinical Cancer Research: Cr 24(4): 585-593

Huang, C.-x.; Yu, H.; Yang, G.-g.; Wang, Q.-q.; Shen, F.-p.; Li, D.; Cao, X.-t. 2005: Antitumor therapeutic effect induced by intestine-carcinoma cells vaccine expressing membrane-bound heat shock protein 70. Zhonghua Wei Chang Wai Ke Za Zhi 8(3): 255-258

Tagliaferri, P.; Tassone, P.; Blotta, S.; Viscomi, C.; Grillone, F.; Budillon, A.; Caraglia, M.; Venuta, S. 2005: Antitumor therapeutic strategies based on the targeting of epidermal growth factor-induced survival pathways. Current Drug Targets 6(3): 289-300

Ishii, K.J.; Kawakami, K.; Gursel, I.; Conover, J.; Joshi, B.H.; Klinman, D.M.; Puri, R.K. 2003: Antitumor therapy with bacterial DNA and toxin: complete regression of established tumor induced by liposomal CpG oligodeoxynucleotides plus interleukin-13 cytotoxin. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 9(17): 6516-6522

Caruso, F.; Rossi, M. 2004: Antitumor titanium compounds and related metallocenes. Metal Ions in Biological Systems 42: 353-384

Wang, Y.; Perchellet, E.M.; Ward, M.M.; Lou, K.; Zhao, H.; Battina, S.K.; Wiredu, B.; Hua, D.H.; Perchellet, J.-P.H. 2006: Antitumor triptycene analogs induce a rapid collapse of mitochondrial transmembrane potential in HL-60 cells and isolated mitochondria. International Journal of Oncology 28(1): 161-172

Steiner, H.H.; Bonsanto, M.M.; Beckhove, P.; Brysch, M.; Geletneky, K.; Ahmadi, R.; Schuele-Freyer, R.; Kremer, P.; Ranaie, G.; Matejic, D.; Bauer, H.; Kiessling, M.; Kunze, S.; Schirrmacher, V.; Herold-Mende, C. 2004: Antitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefit. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 22(21): 4272-4281

Skinner, K.A. 2005: Antitumor vaccines: of mice and men?. Annals of Surgical Oncology 12(7): 511-512

Yano, S.; Muguruma, H.; Matsumori, Y.; Goto, H.; Nakataki, E.; Edakuni, N.; Tomimoto, H.; Kakiuchi, S.; Yamamoto, A.; Uehara, H.; Ryan, A.; Sone, S. 2005: Antitumor vascular strategy for controlling experimental metastatic spread of human small-cell lung cancer cells with ZD6474 in natural killer cell-depleted severe combined immunodeficient mice. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(24 Part 1): 8789-8798

Feldman, E.B.; Silverstein, J.N.; Nayak, R.V.; Carter, A.C. 1962: Antitumor, endocrine, and metabolic effects of 16alpha-estradiol dipropionate in women with breast cancer. Cancer 15: 1073-1075

Guillem, E.B.á; Sampsel, J.W. 2006: Antitumor-associated antigens IgGs: dual positive and negative potential effects for cancer therapy. Advances in Experimental Medicine and Biology 587: 341-374

Huant, E. 1955: Antitumoral action of a hypotoxic derivative of colchicine: deacetylthiocolchicine; clinical aspects and first therapeutic results: 16 case reports. Therapie 10(3): 448-456

De Cort, J. 1956: Antitumoral action of actinomycins in mice. Bulletin de l'Association Francaise Pour l'Etude du Cancer 43(1): 112-118

Herskind, C.; Fleckenstein, K.; Lohr, J.; Li, C-Yuan.; Wenz, F.; Lohr, F. 2004: Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 180(4): 187-193

Herskind, C.; Fleckenstein, K.; Lohr, J.; Li, C.-Y.; Wenz, F.; Lohr, F. 2004: Antitumoral action of interferons and interleukins in combination with radiotherapy. Part II: radiobiological and immunologic strategies. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 180(6): 331-339

Guareschi, C.; Serchi, G.; Anichini, C. 1954: Antitumoral action of some phospho-riboflavin-metallic complexes. Giornale Italiano di Chemioterapia 1(1): 214-215

Baldini, L.; Brambilla, G. 1959: Antitumoral action of triethylene melamine-isonicotinic acid hydrazide association on Galliera sarcoma of the rat. Bollettino della Societa Italiana di Biologia Sperimentale 35: 1171-1175

Guareschi, C.; Anichini, C. 1954: Antitumoral action of various riboflavin phosphate-metal complexes. Bollettino della Societa Italiana di Biologia Sperimentale 30(6): 752-755

Menendez, J.A.; Vellon, L.; Lupu, R. 2005: Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene. Annals of Oncology: Official Journal of the European Society for Medical Oncology 16(8): 1253-1267

Wienecke, R.; Fackler, I.; Linsenmaier, U.; Mayer, K.; Licht, T.; Kretzler, M. 2006: Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 48(3): E27-E29

Kraus, J.; Blaschek, W.; Franz, G. 1988: Antitumoral and Immunological Properties of a beta-1,3/1,6-Glucan from Phytophthora parasitica. Planta Medica 54(6): 565

Dietrich, A.; Kraus, K.; Brinckmann, U.; Stockmar, C.; Müller, A.; Liebert, U.Gerd.; Schönfelder, M. 2003: Antitumoral and antimetastatic effects of continuous particle-mediated cytokine gene therapy. Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 162: 157-168

Canonico, A.N. 1960: Antitumoral chemotherapy as a supplement in the surgery of cancer. Prensa Medica Argentina 47: 803-808

Lasalvia-Prisco, E.; Cucchi, S.; Vázquez, J.ús.; Lasalvia-Galante, E.; Golomar, W.; Gordon, W. 2003: Antitumoral effect of a vaccination procedure with an autologous hemoderivative. Cancer Biology and Therapy 2(2): 155-160

Malka, D.; Pacault, V.; De Baere, T.; Ducreux, M.; Boige, V.ér. 2005: Antitumoral effect of celecoxib in hepatocellular carcinoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 23(21): 4805-4806

Iglesias, R. 1957: Antitumorigenic and tumor-stimulating actions of steroid hormones. Cancer 10(4): 734-737

Sablik, J.; Sorm, F. 1957: Antitumorous action of 6-azauracil on some transplantable experimental tumours. Neoplasma 4(2): 113-117

Kaplan, M.A.; Bradner, W.T.; Buckwalter, F.H.; Pindell, M.H. 1965: Antitumour Activity of N-(Beta,beta'-Dichlorodiethylaminomethyl)-Tetracycline, 'tetracycline-Mustard'. Nature 205: 399-400

Zhang, S.; Jiang, S.-j.; Zhang, C.-q.; Wang, H.-m.; Bai, C.-x. 2005: Antitumour activities of cytokine-induced killer cells and dendritic cells in vitro and in vivo. Chinese Medical Journal 118(15): 1308-1312

Kumazawa, E.; Tohgo, A. 1998: Antitumour activity of DX-8951f: a new camptothecin derivative. Expert Opinion on Investigational Drugs 7(4): 625-632

Gutermuth, J.; Audring, H.; Voit, C.; Trefzer, U.; Haas, N. 2004: Antitumour activity of paclitaxel and interferon-alpha in a case of metastatic eccrine porocarcinoma. Journal of the European Academy of Dermatology and Venereology: Jeadv 18(4): 477-479

Lord, S.; Ghersi, D.; Gattellari, M.; Wortley, S.; Wilcken, N.; Simes, J. 2004: Antitumour antibiotic containing regimens for metastatic breast cancer. Cochrane Database of Systematic Reviews 4: Cd003367

Casely-Hayford, M.A.; Kerr, N.O.; Smith, E.; Gibbons, S.; Searcey, M. 2005: Antitumour antibiotics with potent activity against multidrug resistant (MDR) Staphylococcus aureus: a new approach to targeting resistant bacteria. Medicinal Chemistry 1(6): 619-627

Holeckova, E.; Sekla, B. 1957: Antitumour effect of culture media from tumour-immune spleens. Nature 180(4597): 1298

Syro, L.V.; Uribe, H.; Penagos, L.C.; Ortiz, L.D.; Fadul, C.E.; Horvath, E.; Kovacs, K. 2006: Antitumour effects of temozolomide in a man with a large, invasive prolactin-producing pituitary neoplasm. Clinical Endocrinology 65(4): 552-553

Mitra, R.; Singh, S.; Khar, A. 2003: Antitumour immune responses. Expert Reviews in Molecular Medicine 5(3): 1-19

Heald, R.A.; Stevens, M.F.G. 2003: Antitumour polycyclic acridines. Palladium(0) mediated syntheses of quino[4,3,2-kl]acridines bearing peripheral substituents as potential telomere maintenance inhibitors. Organic and Biomolecular Chemistry 1(19): 3377-3389

Bradner, W.T.; Pindell, M.H. 1962: Antitumour properties of phleomycin. Nature 196: 682-683

Asche, C. 2005: Antitumour quinones. Mini Reviews in Medicinal Chemistry 5(5): 449-467

Liu, S.; Yang, H.; Tang, Z.; Liang, C. 2003: Antitumour study with combined IL-2 gene therapy and radiation for head and neck squamous cell carcinoma. Lin Chuang Er Bi Yan Hou Ke Za Zhi 17(2): 105-107

Dyckhoff, G.; Herold-Mende, C. 2005: Antitumour vaccination in patients with ENT tumours. Successful track record. Hno 53(3): 209-212

Lipschutz, A. 1953: Antitumoural autodefense. Texas Reports on Biology and Medicine 12(1): 115-125

Iglesias, R.; Lipschutz, A.; Mardones, E. 1951: Antitumourigenic action of steroids as an 'independent' faculty of these compounds. Nature 167(4241): 235-236

Maffii, G.; Silvestrini, B.; Banfi, S. 1963: Antitussive Activity of a new Local Anesthetic Compound: Benzobutamine. Nature 199: 916-917

Ota, Y.; Endo, N.; Hirasawa, M. 1964: Antitussive Activity of Narcotine Derivatives. Chemical and Pharmaceutical Bulletin 12: 569-578

Salem, H.; Aviado, D.M. 1964: Antitussive Drugs, with Special Reference to a new Theory for the Initation of the Cough Reflex and the Influence or Bronchodilators. American Journal of the Medical Sciences 247: 585-600

Boissier, J.R.; Pagny, J. 1959: Antitussive action of a non-barbituric hypnotic, metolquizolone. Medicina experimentalis: International journal of experimental medicine 1: 368-372

Suriani, U. 1958: Antitussive action of a polyethylene derivative of pantocaine studies in anesthesia for otorhinolaryngological surgery. L'Oto-Rino-Laringologia Italiana 26(5): 377-387

Winter, C.A.; Flataker, L. 1952: Antitussive action of d-isomethadone and d-methadone in dogs. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 81(2): 463-465

Boissier, J.R.; Pagny, J. 1960: Antitussive action of some phenothiazines. Therapie 15: 97-102

Ozawa, H.; Fukuda, H.; Otsuki, I.; Chiba, S. 1962: Antitussive activity and acute toxicity of 2-(2-diethylamino-ethoxy)ethyl alpha,alpha-diethylphenylacetate (oxeladin). Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 82: 1314-1317

Epstein, O.I.; Kovaleva, V.L.; Zak, M.S. 2003: Antitussive activity of Anar. Bulletin of Experimental Biology and Medicine 135(Suppl 7): 96-98

Morais, M.; da SILVA, J. 1961: Antitussive agents with central action. Portugal Medico 45: 32-49

David, A.; Leith-Ross, F.; Vallance, D.K. 1957: Antitussive and other pharmacological properties of the diethylaminoethoxyethyl ester of alpha alpha-diethylphenylacetic acid, (oxeladin). Journal of Pharmacy and Pharmacology 9(7): 446-458

Gaarenstroom, J.H. 1959: Antitussive drugs. Nederlands Tijdschrift Voor Geneeskunde 103(22): 1149-1152

Hengen, O.; Kasparek, H. 1958: Antitussive effect of a new substance. Arzneimittel-Forschung 8(9): 620

Franova, S.; Nosalova, G. 2004: Antitussive effect of diltiazem in experimental conditions. Bratislavske Lekarske Listy 105(5-6): 203-206

Jimenez-Vargas, J.; Balague, A.; Sarria, J. 1961: Antitussive effect of the inhibition of carbonic anhydrase. Revista Espanola de Fisiologia 17: 1-10

Christoffel, P.; Kolberg, H. 1958: Antitussive effects of an aminonitrile. Medizinische Klinik 53(35): 1507-1509

Mcclellan, M. 1960: Antitussive effects of trimeprazine (temaril) in children. Ohio State Medical Journal 56: 1358-1359

Silbert, N.E. 1961: Antitussive medication in asthma, emphysema and chronic bronchitis. Acta Allergologica 16: 232-253

Plisnier, H. 1958: Antitussive properties of a quaternary ammonium bromide: 2-trimethylamino-1, 2-diphenyldiethylether bromide. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 152(8-9): 1267-1268

Weiss, R.F. 1961: Antitussive teas and other antitussive plant drugs. Hippokrates 32: 14-18

Grabelle, B.N. 1961: Antitussive therapy with pholcodine. Journal of the Medical Society of new Jersey 58: 563-565

Boissier, J.R. 1957: Antitussives: methods of study; results obtained. Produits Pharmaceutiques 12(1): 33-37 Concl

Boissier, J.R. 1956: Antitussives; study technics; results obtained. Produits Pharmaceutiques 11(12): 867

Ibadin, M.O.; Ogbimi, A. 2004: Antityphoid agglutinins in African school aged children with malaria. West African Journal of Medicine 23(4): 276-279

Cattaneo, A.; Zanini, G. 1952: Antityphoid therapy with chloramphenicol. Archivio di Farmacologia Sperimentale e Scienze Affini 80(11-12): 263-275

Cavallotti, A.M. 1952: Antityphoid therapy with chloramphenicol; evaluation after two years of experimental use. Minerva Medica 43(39): 1006-1011

Videla, C.A. 1949: Antityphus immunotherapy. El Dia Medico 21(64): 2430

Grupper, C.; Legrand, J.C.; Gonnard, P. 1964: Antityrosinase Activity of the Serum of Patients with Malignant Melanoma: Demonstration with the Aid of the Warburg Apparatus. Archiv für Klinische und Experimentelle Dermatologie 219: 784-789

Sos, J.; Csalay, L.; Gati, T.; Kemeny, T.; Kertai, P.; Nagy, E.; Perenyi, L.; Szabo, G. 1957: Antityrosine compounds. Kiserletes Orvostudomany 9(5-6): 570-574

Kaminka, M.E.; Kalinkina, M.A.; Pushkina, T.V.; Tupikina, S.M.; Riabova, O.B.; Makarov, V.A.; Granik, V.G. 2004: Antiulcer activity of furoxanopyrimidine derivatives. Eksperimental'naia i Klinicheskaia Farmakologiia 67(3): 30-33

Krylova, S.G.; Zueva, E.P.; Razina, T.G.; Amosova, E.N.; Shilova, N.V.; Dugina, Y.L.; Epstein, O.I. 2003: Antiulcer activity of ultralow doses of antibodies to histamine under experimental conditions. Bulletin of Experimental Biology and Medicine 135(Suppl 7): 80-82

Bhatnagar, M.; Sisodia, S.S.; Bhatnagar, R. 2005: Antiulcer and antioxidant activity of Asparagus racemosus Willd and Withania somnifera Dunal in rats. Annals of the new York Academy of Sciences 1056: 261-278

Samonina, G..E..; Kopylova, G..N..; Lukjanzeva, G..V..; Zhuykova, S..E..; Smirnova, E..A..; German, S..V..; Guseva, A..A.. 2004: Antiulcer effects of amylin: a review. Pathophysiology: the Official Journal of the International Society for Pathophysiology 11(1): 1-6

Zhuĭkova, S.E.; Badmaeva, K.E.; Bakaeva, Z.V.; Samonina, G.E. 2004: Antiulcer effects of the tripeptide PGP and its possible metabolites (PG, GP, glycine, and proline) in different models of ulcer induction in rats. Izvestiia Akademii Nauk. Seriia Biologicheskaia 5: 585-588

Debray, C.; Reversat, R. 1950: Antiulcer extracts taken from the gastrointestinal mucosa and the urine. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 26(50): 2419-2429

Merson, M.I. 1954: Antiulcerin in complex therapy of amphodontosis. Stomatologiia 5: 12-13

Frenkl, R.; Csalay, L.; Makara, G.; Harmos, G. 1964: Antiulcerogenic Effect of Exercise in Rats. Acta physiologica Academiae Scientiarum Hungaricae 25: 97-100

Datta, G.K.; Sairam, K.; Priyambada, S.; Debnath, P.K.; Goel, R.K. 2002: Antiulcerogenic activity of Satavari mandur--an Ayurvedic herbo-mineral preparation. Indian Journal of Experimental Biology 40(10): 1173-1177

Melnotte, P. 1956: Antivaccinal campaigns and public health. Revue d'Hygiene et de Medecine Sociale 4(4): 417-426

Semple, A.B.; Parry, W.H.; Hobday, T.L. 1959: Antivaccinial gamma-globulin; a further report on smallpox prophylaxis. Lancet 2(7089): 34

Minelli, R.; Pisati, F. 1962: Antivagal cardiac effect of thiamine and some of its derivatives (neopyrithiamine and hydroxthiamine). Bollettino della Societa Italiana di Biologia Sperimentale 38: 501-504

Gourdeau, H.; Leblond, L.; Hamelin, B.; Desputeau, C.; Dong, K.; Kianicka, I.; Custeau, D.; Boudreau, C.; Geerts, L.; Cai, S.-X.; Drewe, J.; Labrecque, D.; Kasibhatla, S.; Tseng, B. 2004: Antivascular and antitumor evaluation of 2-amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-4H-chromenes, a novel series of anticancer agents. Molecular Cancer Therapeutics 3(11): 1375-1384

Galbraith, S.M. 2003: Antivascular cancer treatments: imaging biomarkers in pharmaceutical drug development. British Journal of Radiology 76(Special Issue 1): S83-S86

Kaiser, P.K. 2006: Antivascular endothelial growth factor agents and their development: therapeutic implications in ocular diseases. American Journal of Ophthalmology 142(4): 660-668

Franson, P.J.; Lapka, D.V. 2005: Antivascular endothelial growth factor monoclonal antibody therapy: a promising paradigm in colorectal cancer. Clinical Journal of Oncology Nursing 9(1): 55-60

Thaker, P.H.; Yazici, S.; Nilsson, M.B.; Yokoi, K.; Tsan, R.Z.; He, J.; Kim, S.-J.; Fidler, I.J.; Sood, A.K. 2005: Antivascular therapy for orthotopic human ovarian carcinoma through blockade of the vascular endothelial growth factor and epidermal growth factor receptors. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(13): 4923-4933

Fidler, I.J. 2006: Antivascular therapy of cancer metastasis. Journal of Surgical Oncology 94(3): 178-180

Baguley, B.C. 2003: Antivascular therapy of cancer: DMXAA. LANCET. Oncology 4(3): 141-148

Yazici, Y.D.; Kim, S.; Jasser, S.A.; Wang, Z.; Carter, K.B.; Bucana, C.D.; Myers, J.N. 2005: Antivascular therapy of oral tongue squamous cell carcinoma with PTK787. Laryngoscope 115(12): 2249-2255

Reid, H.A. 1957: Antivenene reaction following accidental sea-snake bite. British Medical Journal 2(5035): 26-29

Makotchenko, M.M. 1958: Antiveneral legislation and its practical use. Vestnik Dermatologii i Venerologii 32(3): 52-54

Colonieu, L. 1957: Antivenereal campaign in Algiers. La Prophylaxie Sanitaire et Morale 29(3): 66-72

Kalman, E. 1951: Antivenereal campaign in Hungary. Orvosi Hetilap 92(28): 886-892

Acosta Martinez, A.; Anzola Espinoza, H. 1954: Antivenereal campaign in Venezuela. Revista de Sanidad y Asistencia Social 19(5-6): 309-329

De Oliveira, P.P. 1954: Antivenereal campaign in the army in peace time. Hospital (Rio de Janeiro) 45(4): 493-518

Belgodere, G. 1951: Antivenereal prevention; defense of prostitutes. Bulletin Medical 65(23): 540-546

Zeledon, J. 1957: Antivenereal propaganda using motion pictures & movable equipment. Revista Medica de Costa Rica 16(276-278): 70-73

Gougerot, H. 1950: Antivenereal propaganda; summary of a lesson for social workers: Moral, sexual and medical education. La Prophylaxie Antivenerienne 22(2): 60-62

Carpentier, R. 1951: Antivenereal prophylaxis comparative study of homogenous groups. La Semana Medica 27(67): 906-907

Coeurdacier 1953: Antivenereal services in the Vosges in 1952. La Prophylaxie Sanitaire et Morale 25(9): 223-225

Yeung, J.M.; Little, M.; Murray, L.M.; Jelinek, G.A.; Daly, F.F.S. 2004: Antivenom dosing in 35 patients with severe brown snake (Pseudonaja) envenoming in Western Australia over 10 years. Medical Journal of Australia 181(11-12): 703-705

Cheng, A.C.; Winkel, K.D. 2004: Antivenom efficacy, safety and availability: measuring smoke. Medical Journal of Australia 180(1): 5-6

Marqvard, H. 1951: Antivenom serum therapy; research on the neutralization of diffusion factors of poisons. Revue d'Immunologie et de Therapie Antimicrobienne 15(4): 262-270

Schmidt, J.M. 2005: Antivenom therapy for snakebites in children: is there evidence?. Current Opinion in Pediatrics 17(2): 234-238

Hung, D.-Z.; Yu, Y.-J.; Hsu, C.-L.; Lin, T.-J. 2006: Antivenom treatment and renal dysfunction in Russell's viper snakebite in Taiwan: a case series. Transactions of the Royal Society of Tropical Medicine and Hygiene 100(5): 489-494

Isbister, G.K. 2004: Antivenom, anecdotes and evidence. Medical Journal of Australia 181(11-12): 685-686

Arora, R.B. 1956: Antiveratrinic action of Rauwolfia serpentina alkaloids. Archives Internationales de Pharmacodynamie et de Therapie 106(1-2): 28-36

Arora, R.B.; Dandiya, P.C. 1956: Antiveratrinic action of the chemical components of chloroquine and some other chlorine substituted compounds. Indian Journal of Medical Research 44(2): 237-244

Arora, R.B.; Das, P.K. 1956: Antiveratrinic activity of antiarrhythmic drugs. Archives Internationales de Pharmacodynamie et de Therapie 107(2): 202-214

Scolari, R. 1964: Antivertiginous Action of Thiethylperazine. Annali di Laringologia Otologia Rinologia Faringologia 63: 331-335

Perani, G.; Girardi, G. 1963: Antivertigo Action of a new Drug: Torecan. Minerva Otorinolaringologica 13: 313-316

Tipson, R.S. 1963: Antiviral Activity of 2,2-Dichloro-4'-Formylacetanilide Thiosemicarbazone. Journal of Medicinal Chemistry 6: 216-217

Neumayer, E.M.; Haff, R.F.; Hoffman, C.E. 1965: Antiviral Activity of Amantadine Hydrochloride in Tissue Culture and in Ovo. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 119: 393-396

Rightsel, W.A.; Schneider, H.G.; Sloan, B.J.; Graf, P.R.; Miller, F.A.; Bartz, O.R.; Ehrlich, J.; Dixon, G.J. 1964: Antiviral Activity of Gliotoxin and Gliotoxin Acetate. Nature 204: 1333-1334

Cohen, R.A.; Kucera, L.S.; Herrmann, E.C. 1964: Antiviral Activity of Melissa Officinalis (Lemon Balm) Extract. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 117: 431-434

Pollikoff, R.; Lieberman, M.; Lem, N.E.; Foley, E.J. 1965: Antiviral Activity of N-Ethylisatin Beta-Thiosemicarbazone in Vaccinia-Infected Mice. Journal of Immunology 94: 794-804

Fara, G.M.; Cochran, K.W. 1963: Antiviral Activity of Selected Benzimidazoles. Bollettino Dell'istituto Sieroterapico Milanese 42: 630-637

Miller, F.A.; Rightsel, W.A.; Sloan, B.J.; Ehrlich, J.; French, J.C.; Bartz, Q.R.; Dixon, G.J. 1963: Antiviral Activity of Tenuazonic Acid. Nature 200: 1338-1339

Styk, B.; Hana, L.; Rada, B. 1963: Antiviral and Cofactor-Like Activities of some Dextran Sulfates. Acta Virologica 7: 480

Field, H.J.; Hodge, A.Vere.; Brancale, A.; Otto, M.; Sidwells, R.; Baba, M. 2006: Antiviral Chemistry & Chemotherapy's current antiviral agents FactFile 2006 (1st edition). Antiviral Chemistry and ChemoTherapy 17(3): 111-112

Klettenhammer, H.P. 1963: Antiviral Chemoprophylaxis with Flumidin (Abob) for Morbidity Accompanying Colds Among Soldiers in the Austrian Army. Wiener Medizinische Wochenschrift 113: 841-842

Massarani, E.; Mauri, L. 1964: Antiviral Chemotherapeutic Agents. 8. new Glyoxal Derivatives of Diphenyl Ether. Il Farmaco; Edizione Scientifica 19: 958-963

Cavallini, G.; Massarani, E.; Nardi, D.; Mauri, L.; Tenconi, F. 1964: Antiviral Chemotherapeutic Agents. X. Aromatic Mono- and Bis-Aldehydes. Il Farmaco; Edizione Scientifica 19: 964-971

Cavallini, G.; Nardi, D.; Massarani, E. 1964: Antiviral Chemotherapeutic Agents. Xi. Glyoxalic Derivatives of 2-Phenylquinone and 2-Phenylhydroquinone. Bollettino Chimico Farmaceutico 103: 700-708

Cavallini, G.; Nardi, D.; Massarani, E. 1964: Antiviral Chemotherapeutics. V. N,o-Acetals, Schiff Bases, and N,n-Diacetals from 4-Biphenylylglyoxal. Il Farmaco; Edizione Scientifica 19: 597-609

Cavallini, G.; Massarani, E.; Nardi, D. 1964: Antiviral Chemotherapeutics. Vi. N,o-Acetals N,n-Diacetals, and Schiff Bases from Substituted P-Phenylglyoxals. Il Farmaco; Edizione Scientifica 19: 610-617

Cavallini, G.; Massarani, E.; Nardi, D.; Tenconi, F.; Mauri, L. 1964: Antiviral Chemotherapeutics. Vii. Schiff Bases, Isonicotinylhydrazones, N,o-Acetals and N,n-Diacetals of new Aromatic Glyoxals. Il Farmaco; Edizione Scientifica 19: 751-756

Valcurone, G.; Cerri, O. 1963: Antiviral Chemotherapy. Bollettino Chimico Farmaceutico 102: 817-842

Magrassi, F. 1964: Antiviral Chemotherapy as a Basis for Chemotherapy of Blood Diseases and Malignant Neoplasms. La Riforma medica 78: 225-231

Smith, L. 1964: Antiviral Chemotherapy in Prevention of Smallpox. JAMA 187: 145-146

Rey, M.; Guerin, M.; Baylet, R.; Armengaud, M. 1964: Antiviral Chemotherapy Trials in Primary Herpetic Infection of African Children. Bulletin de la Societe Medicale d'Afrique Noire de Langue Francaise 9: 446-451

Cavallini, G.; Massarani, E.; Nardi, D. 1964: Antiviral Compounds. Ix. Steroid Derivatives. Journal of Medicinal Chemistry 7: 673-675

Furukawa, M.; Toyoshima, S.; Ueda, T. 1963: Antiviral effect and Syntheses of 4-Amino-6alkylaminos-Triazine-2-Carboxylic Acid Derivatives. Researches on Chemotherapeutic Drugs against Viruses. Xxxvi. Chemical and Pharmaceutical Bulletin 11: 1247-1250

Peterson, O.P.; Li, Y. 1963: Antiviral effect of Interferon. Voprosy Virusologii 126: 719-724

Anonymous 2005: Antiviral KLEENEX. Medical letter on drugs and therapeutics 47(1199): 3-4

Bobir, A.D.; Ellanska, I.O. 1964: Antiviral Properties of Penicillium L K. Mikrobiolohichnyi Zhurnal 26: 45-48

Esté, Jé.A. 2002: Antiviral Research - 15th International Conference. 17-21 March 2002, Prague, Czech Republic. IDrugs: the investigational drugs journal 5(5): 385-387

Smee, D.F. 2002: Antiviral Research - 15th International Conference. HBV and HCV therapies. 17-21 March 2002, Prague, Czech Republic. IDrugs: the investigational drugs journal 5(5): 392-396

Barnard, D.L. 2002: Antiviral Research - 15th International Conference. Mega-HAART and tenofovir. 17-21 March 2002, Prague, Czech Republic. IDrugs: the investigational drugs journal 5(5): 388-391

Hodge, A.Vere. 2002: Antiviral Research - 15th International Conference. The herpesviruses. 17-21 March 2002, Prague, Czech Republic. IDrugs: the investigational drugs journal 5(5): 397-399

Vere Hodge, A. 2003: Antiviral Research--16th Annual International Conference. Satellite symposium: clinical update on antiviral drugs. 27 April-1 May 2003, Savannah, GA, USA. IDrugs: the investigational drugs journal 6(6): 515-517

Vere Hodge, A. 2003: Antiviral Research--16th International Conference: 27 April-1 May 2003, Savannah, GA, USA. IDrugs: the investigational drugs journal 6(6): 512-514

Smee, D. 2003: Antiviral Research--16th International Congress: HBV and HCV. 27 April-1 May 2003, Savannah, GA, USA. IDrugs: the investigational drugs journal 6(6): 518-521

Smee, D.F. 2000: Antiviral Research. Antiviral targets. Idrugs: the Investigational Drugs Journal 3(7): 754-756

Smee, D.F. 2001: Antiviral Research. Hepatitis viruses. Idrugs: the Investigational Drugs Journal 4(7): 727-730

Vere Hodge, A. 2001: Antiviral Research. Herpes and HIV. Idrugs: the Investigational Drugs Journal 4(7): 723-726

Grierson, K. 2000: Antiviral Research. Poster and late breaker sessions. Idrugs: the Investigational Drugs Journal 3(7): 757-759

Muhsin, M. 2001: Antiviral Research. Poster sessions. Idrugs: the Investigational Drugs Journal 4(7): 735-736

Este, J.A. 2001: Antiviral Research. Retrovirus infections and antiviral research. Idrugs: the Investigational Drugs Journal 4(7): 720-722

Pannecouque, C. 2000: Antiviral Research. Satellite symposium: Clinical update on antiviral drugs. IDrugs: the investigational drugs journal 3(7): 760-761

Grierson, K. 2000: Antiviral Research. Viral infection. Idrugs: the Investigational Drugs Journal 3(7): 749-753

Ciulla, U. 1964: Antiviral Substances in the Treatment of Herpes Simplex Keratitis. South African Medical Journal 38: 357-358

Alatrakchi, N.; Koziel, M.J. 2003: Antiviral T-cell responses and therapy in chronic hepatitis B. Journal of Hepatology 39(4): 631-634

Brug, J.; De Bock, C.A.; Moed, H.D.; Klein, A.J. 1958: Antiviral action of derivatives of omega-aminoacetophenone. British Journal of Pharmacology and ChemoTherapy 13(4): 404-410

Kiseleva, I.I.; Perminova, N.G.; liasunova, O.A.; Timofeev, D.I.; Serbin, A.V.; Kas'ian, L.I.; Egorov, I.A.; Grebinik, T.S.; Timofeev, I.V. 2005: Antiviral action of membranotropic compounds modified by adamantane and norbornene pharmacophores exerted on different HIV-1 strains. Molekuliarnaia Genetika Mikrobiologiia i Virusologiia 2: 33-36

Powell, H.M.; Walcher, D.N.; Mast, C. 1962: Antiviral action of statolon against Coxsackie a 21 (Coe) virus. Antibiotics and ChemoTherapy 12: 337-341

Iwata, A.; Yamaguchi, T.; Sato, K.; Izumi, R.; Tomoda, A. 2003: Antiviral activity of 2-amino-4,4alpha-dihydro-4alpha-7-dimethyl-3H-phenoxazine-3-one on poliovirus. Tohoku Journal of Experimental Medicine 200(3): 161-165

Andreola, M.L.; Nguyen, C.H.; Ventura, M.; Tarrago-Litvak, L.; Legraverend, M. 2001: Antiviral activity of 4-benzyl pyridinone derivatives as HIV-1 reverse transcriptase inhibitors. Expert Opinion on Emerging Drugs 6(2): 225-238

Oberbaum, M.; Glatthaar-Saalmüller, B.; Stolt, P.; Weiser, M. 2005: Antiviral activity of Engystol: an in vitro analysis. Journal of Alternative and Complementary Medicine 11(5): 855-862

Awadh Ali, N.A.; Mothana, R.A.A.; Lesnau, A.; Pilgrim, H.; Lindequist, U. 2003: Antiviral activity of Inonotus hispidus. Fitoterapia 74(5): 483-485

Moorer, W.R. 2003: Antiviral activity of alcohol for surface disinfection. International Journal of Dental Hygiene 1(3): 138-142

Angela, G.C.; Giuliani, G. 1962: Antiviral activity of an analogue of sialic acid (Simo). Action on the influenza virus. Preliminary report. Minerva Medica 53: 761-763

Loginova, S.I.; Koval'chuk, A.V.; Borisevich, S.V.; Syromiatnikova, S.I.; Borisevich, G.V.; Pashchenko, I.I.; Khamitov, R.A.; Maksimov, V.A.; Shuster, A.M. 2004: Antiviral activity of an interferon inducer amixin in experimental West Nile Fever. Voprosy Virusologii 49(2): 8-11

Glotov, A.G.; Glotova, T.I.; Sergeev, A.A.; Belkina, T.V.; Sergeev, A.N. 2004: Antiviral activity of different drugs in vitro against viruses of bovine infectious rhinotracheitis and bovine diarrhea. Voprosy Virusologii 49(5): 43-46

Buckwold, V.E.; Wilson, R.J.H.; Nalca, A.; Beer, B.B.; Voss, T.G.; Turpin, J.A.; Buckheit, R.W.; Wei, J.; Wenzel-Mathers, M.; Walton, E.M.; Smith, R.J.; Pallansch, M.; Ward, P.; Wells, J.; Chuvala, L.; Sloane, S.; Paulman, R.; Russell, J.; Hartman, T.; Ptak, R. 2004: Antiviral activity of hop constituents against a series of DNA and RNA viruses. Antiviral Research 61(1): 57-62

Howell, M.D.; Streib, J.E.; Leung, D.Y.M. 2007: Antiviral activity of human beta-defensin 3 against vaccinia virus. Journal of Allergy and Clinical Immunology 119(4): 1022-1025

Barinskiĭ, I.F.; Alimbarova, L.M.; Platonova, A.A.; Shmelev, V.A. 2004: Antiviral activity of human recombinant gamma-interferon and recombinant hybrid protein of tumor necrosis factor-alpha-thymosin-alpha1 on models of herpes-virus and cytomegalovirus infection in vitro. Voprosy Virusologii 49(5): 37-43

Podol'skaya, S.V.; Naryshkina, N.A.; Sorokoumova, G.M.; Kaplun, A.P.; Fedorova, N.E.; Medzhidova, A.A.; Kuts, A.A.; Shvets, V.I. 2005: Antiviral activity of liposomal preparations of antibiotic geliomycin. Bulletin of Experimental Biology and Medicine 139(3): 349-351

Van Hoof, L.; Robbrecht, V.; Vanden Berghe, D.; De Meyer, N.; Haemers, A.; Vlietinck, A. 1989: Antiviral activity of natural 3-methoxyflavones. Journal of ChemoTherapy 1(4 Suppl): 1081-1082

Vinkemeier, U.; Meyer, T. 2005: Antiviral activity of oligomerization-deficient Stat1. Genome Informatics. International Conference on Genome Informatics 16(1): 44-48

Sergeev, A.N.; P'iankov, O.V.; Shishkina, L.N.; Duben', L.G.; Petrishchenko, V.A.; Zhukov, V.A.; P'iankova, O.G.; Sviatchenko, L.I.; Sherstoboev, E.I.; Karimova, T.V.; Martiushev-Poklad, A.V.; Sergeeva, S.A.; Epshteĭn, O.I.; Glotov, A.G.; Glotova, T.I. 2004: Antiviral activity of oral ultralow doses of antibodies to gamma-interferon: experimental study of influenza infection in mice. Antibiotiki i Khimioterapiia 49(11): 7-11

La Frazia, S.; Amici, C.; Santoro, M.G. 2006: Antiviral activity of proteasome inhibitors in herpes simplex virus-1 infection: role of nuclear factor-kappaB. Antiviral Therapy 11(8): 995-1004

Andronova, V.L.; Skorobogatyĭ, M.V.; Manasova, E.V.; Berlin, I.A.; Korshun, V.A.; Galegov, G.A. 2003: Antiviral activity of some 5-arylethynyl 2'-deoxyuridine derivatives. Bioorganicheskaia Khimiia 29(3): 290-295

Bobir, A.D. 1961: Antiviral activity of some antibiotics and other preparations in relation to the stage of development of viral infections. Mikrobiolohichnyi Zhurnal 23(5): 27-32

De Meyer, N.; Van Hoof, L.; Pandey, H.K.; Mishra, L.; Vanden Berghe, D.; Vlietinck, A.J.; Haemers, A. 1989: Antiviral activity of synthetic 3-methoxyflavones. Journal of ChemoTherapy 1(4 Suppl): 1082-1084

Yu, W.C.; Hui, D.S.C.; Chan-Yeung, M. 2004: Antiviral agents and corticosteroids in the treatment of severe acute respiratory syndrome (SARS). Thorax 59(8): 643-645

Lynd, L.D.; Goeree, R.; O'Brien, B.J. 2005: Antiviral agents for influenza: a comparison of cost-effectiveness data. Pharmacoeconomics 23(11): 1083-1106

Wenner, C.; Nashelsky, J. 2005: Antiviral agents for pregnant women with genital herpes. American Family Physician 72(9): 1807-1808

Bruun, J.N. 2003: Antiviral agents for reduction of mother-to-child transmission of HIV infection. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 123(15): 2041-2042

Patel, R. 2004: Antiviral agents for the prevention of the sexual transmission of herpes simplex in discordant couples. Current Opinion in Infectious Diseases 17(1): 45-48

Uhnoo, I.; Linde, A. 2005: Antiviral agents in influenza--current recommendations. Anti-influenza agents are not a substitution for but a complement to vaccination. Lakartidningen 102(49): 3802

Bruun, J.N. 2003: Antiviral agents reduce HIV transmission from mother to child. Current combination therapy results in best suppression of the virus. Lakartidningen 100(44): 3506-3508

Nosik, N.N.; Nebol'sin, V.E.; Zheltukhina, G.A.; Evstigneeva, R.P.; Kondrashina, N.G.; Lavrukhina, L.A.; Krzhechkovskaia, V.V. 2003: Antiviral and anti-stress activity of the gamma-L-glutamyl-histamine and its derivatives. Voprosy Virusologii 48(1): 38-42

Money, D.M. 2003: Antiviral and antiretroviral use in pregnancy. Obstetrics and Gynecology Clinics of North America 30(4): 731

Aboulafia, D.M.; Ratner, L.; Miles, S.A.; Harrington, W.J. 2006: Antiviral and immunomodulatory treatment for AIDS-related primary central nervous system lymphoma: AIDS Malignancies Consortium pilot study 019. Clinical Lymphoma and Myeloma 6(5): 399-402

Morris, K.V.; Rossi, J.J. 2006: Antiviral applications of RNAi. Handbook of Experimental Pharmacology 2006(173): 105-116

Bauer, D.J.; Sheffield, F.W. 1959: Antiviral chemotherapeutic activity of isatin beta-thiosemicarbazone in mice infected with rabbit-pox virus. Nature 184(Suppl. 19): 1496-1497

Brooks, M.J.; Sasadeusz, J.J.; Tannock, G.A. 2004: Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline?. Current Opinion in Pulmonary Medicine 10(3): 197-203

Ravina, A. 1962: Antiviral chemotherapy. Clinical effects of xenalamine and xenedial. L' Annee Therapeutique 33: 124-127

Cutting, W.C.; Dreisbach, R.H.; Azima, M.; Neff, B.J.; Brown, B.J.; Wray, J. 1951: Antiviral chemotherapy. V. Further report on flavonoids. Stanford Medical Bulletin 9(4): 236-242

Dreisbach, R.H.; Neff, B.J. 1949: Antiviral chemotherapy; pyrimidines, purines, and related compounds. Stanford Medical Bulletin 7(4): 193-195

Cavallini, G.; Massarani, E.; Nardi, D. 1960: Antiviral compounds--II. Reaction of 4-biphenylglyoxal with p-aminobenzoic acid and related structures. Journal of Medicinal and Pharmaceutical Chemistry 2: 99-106

Takaori, A. 2005: Antiviral defense by APOBEC3 family proteins. Uirusu 55(2): 267-272

Cochrane, A.B. 2006: Antiviral dosing and efficacy for prophylaxis of cytomegalovirus disease in solid organ transplant recipients. American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 63(19 Suppl 5: S17-S21

Wu, Y-Shan.; Lin, W-Hsing.; Hsu, J.T-A.; Hsieh, H-Pang. 2006: Antiviral drug discovery against SARS-CoV. Current Medicinal Chemistry 13(17): 2003-2020

Izzedine, H.; Launay-Vacher, V.; Isnard-Bagnis, C.; Deray, G. 2003: Antiviral drug-induced kidney and electrolytes disorders. Minerva Urologica e Nefrologica 55(3): 157-172

Izzedine, H.; Launay-Vacher, V.; Deray, G. 2005: Antiviral drug-induced nephrotoxicity. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 45(5): 804-817

Parvis, D. 1962: Antiviral drugs and bacteriophagic lysis. Archivio Italiano di Scienze Farmacologiche 12: 200-205

Singh, N. 2006: Antiviral drugs for cytomegalovirus in transplant recipients: advantages of preemptive therapy. Reviews in Medical Virology 16(5): 281-287

De Clercq, E. 2004: Antiviral drugs in current clinical use. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 30(2): 115-133

Anonymous 2006: Antiviral drugs in influenza: an adjunct to vaccination in some situations. Prescrire International 15(81): 21-30

Colgan, R.; Michocki, R.; Greisman, L.; Moore, T.A.W. 2003: Antiviral drugs in the immunocompetent host: part I. Treatment of hepatitis, cytomegalovirus, and herpes infections. American Family Physician 67(4): 757

Colgan, R.; Michocki, R.; Greisman, L.; Moore, T.A.W. 2003: Antiviral drugs in the immunocompetent host: part II. Treatment of influenza and respiratory syncytial virus infections. American Family Physician 67(4): 763

Anonymous 2006: Antiviral drugs prophylaxis and treatment of influenza. Medical Letter on Drugs and Therapeutics 48(1246): 87-88

Provencher, Véronic.Marie.Isabelle.; Coccaro, E.; Lacasse, J.Jacques.; Schang, L.María. 2004: Antiviral drugs that target cellular proteins may play major roles in combating HIV resistance. Current Pharmaceutical Design 10(32): 4081-4101

Fang, J.-g.; Hu, Y.; Tang, J.; Wang, W.-q.; Yang, Z.-q. 2005: Antiviral effect of Folium Isatidis on herpes simplex virus type i. Zhongguo Zhong Yao Za Zhi 30(17): 1343-1346

Vershinina, M.I.; Deriabin, P.G.; Mezentseva, M.V.; Narovlianskiĭ, A.N. 2003: Antiviral effect of alpha-interferon and cytokine mRNA level in cell cultures infected with a cytopathogenic variant of the hepatitis C virus. Voprosy Virusologii 48(1): 26-30

Jiang, J.; Li, S.; Li, M.; Xiang, J. 2004: Antiviral effect of chinonin against herpes simplex virus. Journal of Huazhong University of Science and Technology. Medical Sciences 24(5): 521-524

Ueda, T.; Toyoshima, S.; Tsuji, T.; Seto, Y.; Nomoto, J. 1961: Antiviral effect of guanidine and its derivatives. I. the inhibitory effect of guanidine on the multiplication of poliomyelitis virus in tissue culture. Keio Journal of Medicine 10: 257-265

Xing, L.-h.; Wang, F.-s.; Zhu, C.-l. 2003: Antiviral effect of human CTLs activated by HBsAg stimulated dendritic cells in vitro. Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 17(4): 365-368

Jansen, P.L.M.; Reesink, H.W. 2006: Antiviral effect of peginterferon alfa-2b and alfa-2a compared. Journal of Hepatology 45(2): 172-173

Yang, G.; Wang, Y.; Zhao, X.; Han, F.; Wu, S.; Hou, Y. 2002: Antiviral effect of recombinant antibody to influenza virus HA antigen. Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 16(4): 337-340

Katsura, S.; Tsuruma, M. 1957: Antiviral effect of tropolon compounds. Zentralblatt für Bakteriologie Parasitenkunde Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-Hygienische Bakteriologie Virusforschung und Parasitologie. Originale 168(5-6): 378-380

Akihama, S.; Toyoshima, S. 1962: Antiviral effect of zinc complexes on Japanese B encephalitis virus. Chemical and Pharmaceutical Bulletin 10: 1254-1257

Loginova, S.I.; Koval'chuk, A.V.; Borisevich, S.V.; Kopylova, N.K.; Pashchenko, I.I.; Khamitov, R.A.; Maksimov, V.A.; Shuster, A.M. 2005: Antiviral effectiveness of the combined use of amixine and virasole in experimental hemorrhagic fever with renal syndrome in sucking albino mice. Voprosy Virusologii 50(6): 30-32

Zhao, W.; Chen, H.; Peng, Z.-y.; Li, W.-g.; Xi, H.-l.; Xu, X.-y. 2005: Antiviral effects of dual-target antisense rna: an experimental study with hepatitis B virus transgenic mice. Zhonghua Yi Xue Za Zhi 85(49): 3486-3490

Antinori, A.; Trotta, M.P.; Nasta, P.; Bini, T.; Bonora, S.; Castagna, A.; Zaccarelli, M.; Quirino, T.; Landonio, S.; Merli, S.; Tozzi, V.; Di Perri, G.; Andreoni, M.; Perno, C.F.; Carosi, G. 2006: Antiviral efficacy and genotypic resistance patterns of combination therapy with stavudine/tenofovir in highly active antiretroviral therapy experienced patients. Antiviral Therapy 11(2): 233-243

Fischer, A.; Karasi, J.-C.; Kibibi, D.; Omes, C.; Lambert, C.; Uwayitu, A.; Hemmer, R.; Ende, J.; Schmit, J.-C.; Arendt, V. 2006: Antiviral efficacy and resistance in patients on antiretroviral therapy in Kigali, Rwanda: the real-life situation in 2002. HIV Medicine 7(1): 64-66

Lanier, E.R.; Ait-Khaled, M.; Scott, J.; Stone, C.; Melby, T.; Sturge, G.; St Clair, M.; Steel, H.; Hetherington, S.; Pearce, G.; Spreen, W.; Lafon, S. 2004: Antiviral efficacy of abacavir in antiretroviral therapy-experienced adults harbouring HIV-1 with specific patterns of resistance to nucleoside reverse transcriptase inhibitors. Antiviral Therapy 9(1): 37-45

Sweeney, S.E.; Mo, L.; Firestein, G.S. 2007: Antiviral gene expression in rheumatoid arthritis: role of IKKepsilon and interferon regulatory factor 3. Arthritis and Rheumatism 56(3): 743-752

Openshaw, P.J.M. 2005: Antiviral immune responses and lung inflammation after respiratory syncytial virus infection. Proceedings of the American Thoracic Society 2(2): 121-125

Davies, J.K.; Koh, M.B.c.; Lowdell, M.W. 2004: Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 10(4): 259-268

Hayden, F.G.; Pavia, A.T. 2006: Antiviral management of seasonal and pandemic influenza. Journal of Infectious Diseases 194(Suppl 2): S119-S126

Hamano, K.; Sakamoto, N.; Enomoto, N. 2004: Antiviral mechanism of ribavirin against RNA virus. Nihon Rinsho. Japanese Journal of Clinical Medicine 62 Suppl 7(Part 1): 459-462

Gallois-Montbrun, S.; Veron, M.; Deville-Bonne, D. 2004: Antiviral nucleoside analogs phosphorylation by nucleoside diphosphate kinase. Mini Reviews in Medicinal Chemistry 4(4): 361-369

Vincent, D. 1953: Antiviral plants. La Presse Medicale 61(20): 417

Zhang, X.; Huang, C.; Qin, Q. 2004: Antiviral properties of hemocyanin isolated from shrimp Penaeus monodon. Antiviral Research 61(2): 93-99

Germanova, K.I. 1959: Antiviral properties of new antibiotics 1212 and 452-7; effect on influenza virus, certain neuroviruses and herpes virus. Voprosy Virusologii 4(1): 71-76

Bobyr, A.D. 1959: Antiviral properties of products of vital functions of fungi from the family Mortierella. Mikrobiolohichnyi Zhurnal 21(5): 36-39

Germanova, K.I.; Savel'eva, A.M. 1961: Antiviral properties on a new antibiotic polymycin. Antibiotiki 6: 293-298

Cornella, C.; Torazza, M.C.; Strippoli, G.F.M.; Segoloni, G. 2007: Antiviral prophylaxis and pre-emptive therapy for the prevention of Cytomegalovirus infection in renal transplant recipients: guideline from the Italian Society of Nephrology. Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 24 Suppl. 37: S165-S178

Fusman, G.; Balicer, R.D.; Huerta, M.; Davidovitch, N.; Frimer, R.; Leventhal, A.; Grotto, I. 2005: Antiviral prophylaxis following possible sexual exposure to HIV. Harefuah 144(4): 255-260; 303

Sandherr, M.; Einsele, H.; Hebart, H.; Kahl, C.; Kern, W.; Kiehl, M.; Massenkeil, G.; Penack, O.; Schiel, X.; Schuettrumpf, S.; Ullmann, A.J.; Cornely, O.A. 2006: Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO). Annals of oncology: official journal of the European Society for Medical Oncology 17(7): 1051-1059

Bush, K.A.; McAnulty, J.; McPhie, K.; Reynolds, R.; Boomer, M.; Clarkson, L.M.; Quaine, J.; Dwyer, D.E. 2004: Antiviral prophylaxis in the management of an influenza outbreak in an aged care facility. Communicable Diseases Intelligence Quarterly Report 28(3): 396-400

Celkan, T.; Ozkan, A.; Apak, H.; Yildiz, I. 2006: Antiviral prophylaxis with continuous low dose acyclovir in childhood cancer. Leukemia and Lymphoma 47(7): 1418-1420

Poccia, F.; Agrati, C.; Martini, F.; Capobianchi, M.R.; Wallace, M.; Malkovsky, M. 2005: Antiviral reactivities of gammadelta T cells. Microbes and Infection 7(3): 518-528

Barnard, D. 2001: Antiviral research - 14th International Conference. 8-13 April 2001, Seattle, WA, USA. IDrugs: the investigational drugs journal 4(7): 717-719

De Clercq, E. 2004: Antiviral research at the Rega Institute (KU leuven), now 50 years old. Antiviral Chemistry and ChemoTherapy 15(5): 223-233

Watt, J. 2006: Antiviral research--19th international conference. 7-11 May 2006, San Juan, Puerto Rico. IDrugs: the investigational drugs journal 9(7): 467-468

Watt, J. 2006: Antiviral research--19th international conference. Treatments for smallpox and hepatitis. 7-11 May 2006, San Juan, Puerto Rico. IDrugs: the investigational drugs journal 9(7): 469-470

Hayden, F.G. 2006: Antiviral resistance in influenza viruses--implications for management and pandemic response. New England Journal of Medicine 354(8): 785-788

Pyrc, K.; Berkhout, B.; van der Hoek, L. 2007: Antiviral strategies against human coronaviruses. Infectious Disorders Drug Targets 7(1): 59-66

Blattner, R.J. 1954: Antiviral substances. Journal of Pediatrics 44(2): 228-230

Blattner, R.J. 1962: Antiviral substances: treatment of herpes simplex keratitis by 5-iodo-2'-deoxyuridine. Journal of Pediatrics 61: 792-794

Lee, J.-B.; Hayashi, K.; Hirata, M.; Kuroda, E.; Suzuki, E.; Kubo, Y.; Hayashi, T. 2006: Antiviral sulfated polysaccharide from Navicula directa, a diatom collected from deep-sea water in Toyama Bay. Biological and Pharmaceutical Bulletin 29(10): 2135-2139

Drew, W.L.; Miner, R.; Saleh, E. 1993: Antiviral susceptibility testing of cytomegalovirus: criteria for detecting resistance to antivirals. Clinical and Diagnostic Virology 1(3): 179-185

Perry, L.; Balfe, A. 2006: Antiviral therapies. Idrugs: the Investigational Drugs Journal 9(11): 756-758

Kanaan, N.; Goffin, E. 2005: Antiviral therapies for hepatitis-related glomerulonephritis. Lancet 366(9481): 203

Kimberlin, D.W. 2005: Antiviral therapies in children: has their time arrived?. Pediatric Clinics of North America 52(3): 837

Robert, P.-Y.; Liekfeld, A.; Ranger-Rogez, S.; Jaekel, C.; Pleyer, U.; Adenis, J.-P.; Hartmann, C. 2003: Antiviral therapy adjustment in corneal recipients using antibody testing in the aqueous humor. Journal Francais d'Ophtalmologie 26(4): 350-354

Furrer, H.; Telenti, A. 2003: Antiviral therapy and resistance formation exemplified by HIV infection. Therapeutische Umschau. Revue Therapeutique 60(10): 631-635

Tillmann, H.L. 2007: Antiviral therapy and resistance with hepatitis B virus infection. World Journal of Gastroenterology 13(1): 125-140

Sievert, W. 2003: Antiviral therapy for chronic hepatitis C. Australian Family Physician 32(10): 826-832

Iino, S. 2003: Antiviral therapy for chronic viral hepatitis B and C. Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 2): 787-791

Baker, D.A. 2005: Antiviral therapy for genital herpes infections in pregnancy. Expert Review of AntI-Infective Therapy 3(3): 385-392

Hou, J.-l.; Sun, J. 2004: Antiviral therapy for hepatitis C. Zhonghua Gan Zang Bing Za Zhi 12(2): 105

Everson, G.T.; Kulig, C.C. 2006: Antiviral therapy for hepatitis C in the setting of liver transplantation. Current Treatment Options in Gastroenterology 9(6): 520-529

Schmidt, A.C. 2004: Antiviral therapy for influenza : a clinical and economic comparative review. Drugs 64(18): 2031-2046

Tan, J.; Lok, A.S.F. 2007: Antiviral therapy for pre- and post-liver transplantation patients with hepatitis B. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 13(3): 323-326

Triantos, C.; Samonakis, D.; Stigliano, R.; Thalheimer, U.; Patch, D.; Burroughs, A. 2005: Antiviral therapy for recurrent hepatitis C infection after liver transplantation. Transplantation 80(4): 540

Oh, S.; Afdhal, N.H. 2006: Antiviral therapy for treatment naïve patients with hepatitis C virus. Infectious Disease Clinics of North America 20(1): 99

Lau, D.T.-Y.; Membreno, F.E. 2004: Antiviral therapy for treatment-naïve hepatitis B virus patients. Gastroenterology Clinics of North America 33(3): 581-599 IX-X

Geier, A.; Dietrich, C.G.; Gartung, C. 2003: Antiviral therapy in HBe-Ag-positive hepatitis B with normal aminotransferase levels. Hepatology 37(3): 712

Navasa, M.; Forns, X. 2007: Antiviral therapy in HCV decompensated cirrhosis: to treat or not to treat?. Journal of Hepatology 46(2): 185-188

Enright, A.M.; Prober, C. 2003: Antiviral therapy in children with varicella zoster virus and herpes simplex virus infections. Herpes: the Journal of the Ihmf 10(2): 32-37

Yoon, J.-H. 2005: Antiviral therapy in hepatitis B carriers undergoing immunosuppressive treatment or cytotoxic chemotherapy. Korean Journal of Hepatology 11(1): 17-20

Kuo, A.; Terrault, N.A. 2007: Antiviral therapy in liver transplant recipients: is SVR the only endpoint that matters?. Journal of Hepatology 46(3): 359-361

Ozkan, T.B.; Mistik, R.; Dikici, B.; Nazlioglu, H.ül.O. 2007: Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis. Bmc Gastroenterology 7: 9

Lai, C.J.; Terrault, N.A. 2004: Antiviral therapy in patients with chronic hepatitis B and cirrhosis. Gastroenterology Clinics of North America 33(3): 629

Pauschinger, M.; Noutsias, M.; Kühl, U.; Schultheiss, H.-P. 2004: Antiviral therapy in viral heart disease. Herz 29(6): 618-623

Herrine, S.K.; Navarro, V.J. 2006: Antiviral therapy of HCV in the cirrhotic and transplant candidate. International Journal of Medical Sciences 3(2): 75-78

Cui, S.-n.; Wang, M.-m. 2005: Antiviral therapy of chronic hepatitis B patients resistant to lamivudine. Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 19(4): 395-397

Zoulim, F. 2004: Antiviral therapy of chronic hepatitis B: can we clear the virus and prevent drug resistance?. Antiviral Chemistry and ChemoTherapy 15(6): 299-305

Schleiss, M.R. 2005: Antiviral therapy of congenital cytomegalovirus infection. Seminars in Pediatric Infectious Diseases 16(1): 50-59

Amarapurkar, D.N.; Patel, N.D.; Kamani, P. 2005: Antiviral therapy of decompensated cirrhosis due to hepatitis C viral infection. Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 26(3): 119-122

McCullers, J.A. 2005: Antiviral therapy of influenza. Expert Opinion on Investigational Drugs 14(3): 305-312

Tsai, C.-H.; Lee, P.-Y.; Stollar, V.; Li, M.-L. 2006: Antiviral therapy targeting viral polymerase. Current Pharmaceutical Design 12(11): 1339-1355

Peuschel, K.E. 2005: Antiviral therapy with non-selective beta-blockers: preliminary experimental and clinical corroboration. Medical Hypotheses 64(2): 256-260

Salzberger, B. 2006: Antiviral therapy: from influenza to Pfeiffer's disease. Der Internist 47(12): 1245-1250

Quan, D.J.; Peters, M.G. 2004: Antiviral therapy: nucleotide and nucleoside analogs. Clinics in Liver Disease 8(2): 371-385

Kim, J.D.; Sherker, A.H. 2004: Antiviral therapy: role in the management of extrahepatic diseases. Gastroenterology Clinics of North America 33(3): 693-708 Xi

Jablonowski, H. 2005: Antiviral therapy: when to begin, which goals should be set, what must be kept in mind? Tips for nonspecialists. MMW Fortschritte der Medizin 147(Special Issue 1): 10-11

Caplin, B.; Sweny, P.; Burroughs, A.; Emery, V.; Griffiths, P. 2005: Antiviral treatment after solid organ transplantation. Lancet 366(9488): 806

Wutzler, P.; Kossow, K.-D.; Lode, H.; Ruf, B.R.; Scholz, H.; Vogel, G.E. 2004: Antiviral treatment and prophylaxis of influenza in primary care: German recommendations. Journal of Clinical Virology: the Official Publication of the Pan American Society for Clinical Virology 31(2): 84-91

Buster, E.H.C.J.; Janssen, H.L.A. 2006: Antiviral treatment for chronic hepatitis B virus infection--immune modulation or viral suppression?. Netherlands Journal of Medicine 64(6): 175-185

Sood, A.; Midha, V.; Sood, N.; Bansal, M. 2006: Antiviral treatment for chronic hepatitis C: reasons for non-treatment in a Northern Indian center. Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 25(6): 319-320

Xie, Q.; Gui, H.-l. 2006: Antiviral treatment for hepatitis B virus related liver cirrhosis. Zhonghua Gan Zang Bing Za Zhi 14(11): 837-838

Martínez-Bauer, E.; Forns, X. 2003: Antiviral treatment in liver cirrhosis due to hepatitis C virus. Gastroenterologia y Hepatologia 26(5): 303-306

Siebert, U.; Wasem, J.; Rossol, S.; Sroczynski, G.; Aidelsburger, P.; Ravens-Sieberer, U.; Kurth, B.M.; Manns, M.P.; McHutchison, J.G.; Wong, J.B. 2005: Antiviral treatment initiation costs in chronic hepatitis C. Gut 54(1): 172-173

Wang, G.-q. 2005: Antiviral treatment of HBeAg positive chronic hepatitis B. Zhonghua Gan Zang Bing Za Zhi 13(7): 540

Zhaori, G. 2003: Antiviral treatment of SARS: can we draw any conclusions?. Cmaj: Canadian Medical Association Journal 169(11): 1165-1166

Minami, M.; Okanoue, T. 2004: Antiviral treatment of chronic hepatitis B with adefovir dipivoxil. Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 8): 336-339

Kranz, B.; Vester, U.; Bonzel, K.-E.; Paul, A.; Gerken, G.; Hoyer, P.F. 2006: Antiviral treatment of chronic hepatitis B with lamivudine in pediatric renal transplantation. Pediatric Transplantation 10(3): 384-389

Wirth, S. 2006: Antiviral treatment of hepatitis B following solid organ transplantation in children. Pediatric Transplantation 10(3): 271-275

Wang, R.; Du, Z.-L.; Duan, W.-J.; Zhang, X.; Zeng, F.-L.; Wan, X.-X. 2006: Antiviral treatment of hepatitis B virus-transgenic mice by a marine organism, Styela plicata. World Journal of Gastroenterology 12(25): 4038-4043

Postic, B.; Horvath, J.A.; Talwani, R. 2003: Antiviral treatment of human immunodeficiency virus infection: update for 2003. Journal of the South Carolina Medical Association 99(6): 148-153

Samuel, D. 2005: Antiviral treatment of recurrent hepatitis C after liver transplantation: the need for a multifaceted approach. Hepatology 41(3): 436-438

Esser, S. 2006: Antiviral treatment regimens. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 57(11): 961

Bronowicki, J.-P. 2006: Antiviral treatments during cirrhosis. Gastroenterologie Clinique et Biologique 30(6-7): 899-902

Denis, F.; Alain, S.; Hantz, S.; Lagrange, P. 2005: Antiviral vaccination and respiratory mucosal immunity: still disappointing results from a seductive idea. Presse Medicale 34(17): 1245-1253

Geurden, L.M.; Devos, A.; Graulich, R. 1954: Antiviral vaccines and vaccination against viral diseases. Revue de Pathologie Generale et de Physiologie Clinique 54(657): 630-642

Corthout, J.; Pieters, L.; Claeys, M.; Berghe, D.V.; Vlietinck, A.J. 1988: Antivirally Active Gallotannins from Spondias mombin. Planta Medica 54(6): 573

Hewlett, G.; Hallenberger, S.; Rübsamen-Waigmann, H. 2004: Antivirals against DNA viruses (hepatitis B and the herpes viruses). Current Opinion in Pharmacology 4(5): 453-464

Leophonte, P. 2005: Antivirals for influenza. Bulletin de l'Academie Nationale de Medecine 189(2): 341-355; Discussion: 355-357

Smith, J.; Dutkowski, R.; Ward, P. 2006: Antivirals for influenza in healthy adults. Lancet 367(9522): 1571; author reply 1573

Brasseur, D. 2006: Antivirals for influenza in healthy adults. Lancet 367(9522): 1572-3; author reply 1573

Castanedo-Cazares, J.P.; Lepe, V.; Moncada, B. 2004: Antivirals for pityriasis rosae. Photodermatology Photoimmunology and Photomedicine 20(2): 110

Rinaldo, C.H.; Hirsch, H.H. 2007: Antivirals for the treatment of polyomavirus BK replication. Expert Review of AntI-Infective Therapy 5(1): 105-115

Harrod, M.E.; Emery, S.; Dwyer, D.E. 2006: Antivirals in the management of an influenza pandemic. Medical Journal of Australia 185(S10): S58-S61

Chattopadhyay, D.; Naik, T.N. 2007: Antivirals of ethnomedicinal origin: structure-activity relationship and scope. Mini Reviews in Medicinal Chemistry 7(3): 275-301

Horoszewicz, J.S.; Leong, S.S.; Byrd, D.M.; Carter, W.A. 1974: Antivirion effects of streptovaricin complex against Friend virus. Antimicrobial Agents and ChemoTherapy 6(5): 594-597

Pellegrini, A.; Passaggio, A.M.; Pagano, P.G. 1960: Antivirogenetic power of normal and neoplastic human cells and cellular fractions cultivated in vitro. Investigations with radiophosphorus-32P. Minerva Nucleare 4: 88-91

Wang, K.; Samudrala, R.; Mittler, J.E. 2004: Antivirogram or phenosense: a comparison of their reproducibility and an analysis of their correlation. Antiviral Therapy 9(5): 703-712

Bobyr, A.D.; Ellanska, I.O. 1965: Antivirus Properties of Fungi of Genus Penicillium Lk. Federation Proceedings. Translation Supplement; Selected Translations from Medical-Related Science 24: 25-26

Qing, Y.-l.; Zhao, J.-j.; Ren, H. 2004: Antivirus effect of plasmid co expressing hepatitis B surface antigen and granulocyte macrophage-colony stimulating factor. Zhonghua Gan Zang Bing Za Zhi 12(4): 201-204

Wang, Y.-Z.; Cui, X.-L.; Gao, Y.-J.; Guo, S.-S.; Wang, X.-K.; Huang, Y.; Zhao, Y.; Gong, W.-F. 2006: Antivirus effects of extract from gardenia. Zhongguo Zhong Yao Za Zhi 31(14): 1176-1178

Kludas, M.; Knoblauch, R. 1950: Antivirus therapy in dermatology. Zeitschrift für Haut- und Geschlechtskrankheiten 9(11): 472-475

Korner, J. 1952: Antivirus with the follicular hormone in the treatment of gynecological diseases. Medizinische Klinik 47(3): 81

Anonymous 1951: Antivitamin a. Nutrition reviews 9(5): 140-141

Sartori, E.; Peressini, A. 1953: Antivitamin B6 and xanthuria following tryptophan load in children. Acta Paediatrica Latina 6(5): 929-935

Tedeschi, G.G.; De Cicco, A. 1954: Antivitamin e action of thymol, carvacrol, guaiacol. Bollettino della Societa Italiana di Biologia Sperimentale 30(6): 727-729

Moraux, J.; Meunier, P.; Mentzer, C. 1953: Antivitamin K action of alpha-naphthyl-3-hydroxy-4-coumarin. Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences 236(20): 2013-2014

Viscontini, M. 1950: Antivitamin action and its mechanism. Schweizerische Medizinische Wochenschrift 80(29): 763-765

Kutacek, M.; Kratochvil, L. 1958: Antivitamin activity of vegetable extracts. Biokhimiia 23(3): 461-470

Abramson, E. 1953: Antivitamins. Nordisk Medicin 50(34): 1176

Moraux, J. 1956: Antivitamins K and blood coagulation: a new synthetic anticoagulant, alpha-naphthyl-3-hydroxy-4-coumarin. Therapie 11(1): 104-116

Zechmeister, L. 1958: Antivitamins and anti carcinogens. Triangle; the Sandoz Journal of Medical Science 3(6): 218-223

Ryss, S.M. 1950: Antivitamins and role of sulfamides in vitamin metabolism. Klinicheskaia Meditsina 4: 3-12

Albert, A. 1956: Antivitamins, antimetabolites and chemotherapy. British Medical Bulletin 12(1): 67-72

Schopfer, W.H. 1954: Antivitamins; general concepts and present state of the problem. Resenha Clinico-Cientifica 23(11-12): 384-385

De Repentigny, J.; Frappier, A.; Borduas, A.; Desnoyers, J. 1957: Antiwhooping cough activity of human gamma globulin from normal adults. L'Union Medicale du Canada 86(4): 371-374

Grangaud, M.R.; Chardenot, P.; Default, C. 1958: Antixerophthalmic action of 3-hydroxy-4-ketoretinine esters. Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences 246(17): 2532-2534

Massonet, R. 1950: Antixerophthalmic activity of oils of Aristeus antennatus (Penaeidae). Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 144: 1028-1030

Massonet, R. 1955: Antixerophthalmic effect of crustacean chromoprotein in white rat in vitamin a deficiency. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 149: 1971-1976

Krzymien, H. 1958: Antiyeast agglutinins. Polski Tygodnik Lekarski 13(40): 1533-1535

Ulcová-Gallová, Z.; Babcová, K.; Nováková, P.; Micanová, Z.; Rokyta, Z. 2004: Antizonal antibodies in ovulatory cervical mucus and in serum of patients with fertility disorders. Ceska Gynekologie 69(3): 215-218

Mangold, U. 2006: Antizyme inhibitor: mysterious modulator of cell proliferation. Cellular and Molecular Life Sciences: Cmls 63(18): 2095-2101

Richou, R.; Richou, H. 1962: Antizymic properties of cerebrospinal fluids. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 156: 806-807

Kourilsky, R.; Richou, R.; Schlaepfer, J. 1956: Antizymic properties of horse and bovine serums precipitated by anti-horse and anti-bovine rabbit serum. Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences 242(25): 3009-3011

Richou, R.; Kourilsky, R.; Richou, H. 1956: Antizymic properties of rabbit anti-horse and antibovine serums. Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences 242(22): 2674-2675

Kourilsky, R.; Richou, R.; Richou, R. 1956: Antizymic properties of sheep and chicken serum. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 150(10): 1748-1749

Kourilsky, R.; Richou, R.; Pieron, R. 1958: Antizymotic power of human cord blood and maternal blood. Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences 246(1): 186-188

Hurley, M.E.; White, M.J.; Green, A.J.; Kelleher, J. 2004: Antley-Bixler syndrome with radioulnar synostosis. Pediatric Radiology 34(2): 148-151

Bradley, J.P.; Kawamoto, H.K.; Taub, P.; Wexler, A.; Cahan, L. 2003: Antley-Bixler syndrome: correction of facial deformities and long-term survival. Plastic and Reconstructive Surgery 111(4): 1454-1460

Peres, E. 1955: Antlpyresia in children with pyrasulf. Munchener Medizinische Wochenschrift 97(10): 304-305

Milgrom, F.; Witebsky, E. 1963: Antoantibody Formation as a Failure of "self-Recognition". Proceedings. Canadian Cancer Conference 5: 319-336

Ameline, A.; Basset, A. 1952: Antoine Basset (1882-1951). Gynecologie et obstetrique 51(2): 91-92

Anonymous 1920: Anticipation and Realisation. Hospital 69(1802): 268

Belot, J.; Beclere, A. 1952: Antoine Beclère. Vie Medicale 33(Special Issue): 98

Cornet, L.; Bordeu, A. 1953: Antoine Bordeu. Journal de Medecine de Bordeaux et du Sud-Ouest 130(6): 749-750

Charlot, C.; Flahaut, J.; Balard, A.J. 2003: Antoine Jérôme Balard. the man. Revue d'Histoire de la Pharmacie 51(338): 251-264

Huard, P.; Louis, A. 1960: Antoine LOUIS (1723-1792), mirror of his century. Concours Medical 82: 4435-4446

Duveen, D.; Lavoisier, A.LAURENT. 1951: Antoine Laurent Lavoisier (1743-1794): a note regarding his domicile during the French Revolution. Isis; an international review devoted to the history of science and its cultural influences 42(129): 233-234

Duveen, D.I.; Klickstein, H.S.; de Lavoisier, A.-L. 1955: Antoine Laurent Lavoisier's contributions to medicine and public health. Bulletin of the History of Medicine 29(2): 164-179

Duveen, D.; Lavoisier, A. 1950: Antoine Lavoisier's Traité Elémentaire de Chimie; a bibliographical note. Isis; An International Review Devoted to the History of Science and its Cultural Influences 41(124): 168-171

Viel, C.; Fourcroy, A.Francois. 2003: Antoine-Francois de Fourcroy (1755-1809), promoter of Germinal an VI law. Revue d'histoire de la pharmacie 51(339): 377-394

Tan, S.Y.; Hu, M.; Lavoisier, A.-L. 2004: Antoine-Laurent Lavoisier (1743 - 1794): founder of modern chemistry. Singapore Medical Journal 45(7): 303-304

Rappaport, R.; Lavoisier, A.L. 1963: Antoine-Laurent Lavoisier--a biographical sketch (August 26, 1743--May 8, 1794). Journal of Nutrition 79: 3-8

Figueredo, A.V.; Le Marquis, A. 1959: Antoinette Le Marquis. Journal of the American Medical Women's Association 14(6): 530-531

De Souza, J.é C.L.; Athiê, E.; Marigo, C.; Rahal, F.; Fagundes, D.J.é 2005: Antologus and heterotopic splenic regeneration in rats. Acta Cirurgica Brasileira 20(3): 253-257

Manzini, R.; Spelta, O. 1956: Antomical and functional aspects of chronic otorrhea and tympanoplasty. L'Oto-Rino-Laringologia Italiana 24(6): 557-580

Arzt, L.; Von Eiselsberg, A. 1950: Anton Baron of Eiselberg, born July 31, 1860, deceased October 25, 1939. WienerKlinischeWochenschrift 62(35-37): 597

Giudice, P.A.; Chekhov, A.Pavlovich. 1955: Anton Cechov, physician. Minerva Medica 46(46): Varia: 1160-1161

Dewhurst, K. 1955: Anton Chekhov (1860-1904) pioneer in social medicine. Journal of the History of Medicine and Allied Sciences 10(1): 1-16

Todd, J.; Chekhov, A.P. 1954: Anton Chekhov; general practitioner and pioneer in social medicine. Practitioner 173(1037): 605-610

Houssay, B.A.; Carlson, A.J. 1957: Anton J. Carlson; 1875-1956. Revista de la Sociedad Argentina de Biologia 33(1-2): 41-43

Glesinger, L.; Mihelic, A. 1963: Anton Mihelic (1748-1818) and his Contribution to Neurophysiology. Lijecnicki vjesnik 85: 307-315

Wiedmann, A.; Musger, A. 1958: Anton Musger on his 60th birthday. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 9(3): 144

Cortejoso, L.; Chekhov, A.PAVLOVICH. 1960: Anton P. Chekhov, a gloomy life splashed with blood. Boletin Cultural e Informativo - Consejo General de Colegios Medicos de Espana 23: 49-52

Igić, R.; Chekhov, A.Pavlovich. 2005: Anton Pavlovich Chekhov (1860-1904). American journal of psychiatry 162(12): 2248

Bregadze, I.L. 1960: Anton Pavlovich Chekhov in the history of the journal "Khirurgiia". Khirurgiia 36: 130-132

Butter, C.M.; Raederscheidt, A. 2004: Anton Raederscheidt's distorted self-portraits and their significance for understanding balance in art. Journal of the History of the Neurosciences 13(1): 66-78

Baier; Stoss, A. 1952: Anton Stoss 1858-1948. Anatomischer Anzeiger 98(18-20): 352-358

Bulic-Jakus, F.; Juric-Lekic, G.; Svajger, A. 2004: Anton Svajger (1935-2003): pioneer of mammalian developmental biology. Croatian medical journal 45(2): 127-129

Pai-Dhungat, J.V.; Parikh, F.; Van Leeuwenhoek, A. 2006: Anton Van Leeuwenhoek (1632-1723). Postal stamps issued on Leeuwenhoek--Netherland--1937 and Transkei 1982. Journal of the Association of Physicians of India 54: 502

Jantsch, M.; de Haen, A. 1955: Anton de Haen and the beginning of clinical teaching in Vienna; on his 250th birthday, December 8th, 1954. Wiener Klinische Wochenschrift 67(1): 1-3

Narovchatskii, I.P.; Krassovskii, A.I. 1954: Anton lakovlevich Krassovskii. Fel'dsher i Akusherka 11: 28-31

Schonbauer, L.; Von Eiselsberg, A. 1950: Anton von Eiselsberg. Wiener Klinische Wochenschrift 62(35-37): 598-599

Wessling, H.; Simosono, C.L.; Escosa-Bagé, M.; de Las Heras-Echeverría, P. 2006: Anton's syndrome due to a giant anterior fossa meningioma. the problem of routine use of advanced diagnostic imaging in psychiatric care. Acta Neurochirurgica 148(6): 673

Trifiletti, R.R.; Syed, E.H.; Hayes-Rosen, C.; Parano, E.; Pavone, P. 2007: Anton-Babinski syndrome in a child with early-stage adrenoleukodystrophy. European Journal of Neurology 14(2): E11-E12

Sródka, A.; Gluziński, A. 2004: Antoni Gluziński--a classic of Polish internal medicine. Organon 33: 159-168

Tan, S.Y.; van Leeuwenhoek, A. 2003: Antoni van Leeuwenhoek (1632-1723): father of microscopy. Singapore medical journal 44(11): 557-558

Stolk, A. 1952: Antoni van Leeuwenhoek-Huis, Netherlands Cancer Institute. Acta - Unio Internationalis Contra Cancrum 8(Special No): 194-197

Blechmann, G.; Marfan, A.B. 1952: Antonin B. Marfan. Vie Medicale 33(Spec No): 104-106

Léger, P.; Desormeaux, A.J. 2004: Antonin Jean Desormeaux. Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 14(6): 1231-1238

Patel, M.; Poncet, A. 1960: Antonin PONCET (1849-1913). Le Progres Medical 88: 326-333

Proechel, S.; Sanchez Mendez, A. 2004: Antonina Sanchez Mendez. Midwifery Today with International Midwife 2004(71): 56-58

De VASCONCELLOS; Austregesilo, A. 1961: Antonio AUSTREGESILO, master of Brazilian neurology. Medicina Contemporanea 79: 9-13

Tappi, G.; Angeletti, A. 1953: Antonio Angeletti, 1898-1953. Archivio italiano di scienze farmacologiche 3(4): 440-442

Rupp, C.; Austregesilo, A. 1955: Antonio Austregesilo, Jr., 1904-1954. Transactions of the American Neurological Association 1955(80th Meeting): 233

Cecchini, A.; Bareggi, A. 1950: Antonio Bareggi. Lotta Contro la Tubercolosi 20(3-4): 238-240

Whitlock, D.G. 1952: A neurohistological and neurophysiological study of afferent fiber tracts and receptive areas of the avian cerebellum. Journal of Comparative Neurology 97(3): 567-635

Revoltella, G. 1951: Use of sex hormones in obstetrics. Rivista di Ostetricia e Ginecologia 33(8): 369-375

Zannoni, T.; Ceci, A. 1957: Antonio Ceci, 1852-1920. Minerva Medica 48(94): 3959-3960

Vicentini, F.; Cocchi, A. 1951: Antonio Cocchi Mugellano; a clinical case of simple treatment. Minerva Medica 42(78): Varia: 587-588

Broggi, E.; D'ormea, A. 1952: Antonio D'Ormea. Rassegna di Neuropsichiatria e Scienze Affini 6(5): 472-478

Moniz, A.EGAS. 1955: Antonio Egas Moniz. Lancet 269(6904): 1345-1346

Nannini, M.C.; D'este, F.; Ferrarini, A. 1962: Antonio FERRARINI, protophysician of Francesco II d'Este, and one of his consultants. Minerva Medica 53: Varia: 1203-1207

Di Pietro, P.; Frassoni, A. 1952: Antonio Frassoni, professor of Francesco Torti. Minerva Medica 43(37): Varia; 688-92

Girolami, M.; Gasbarrini, A. 1963: Antonio Gasbarrini. Archivio Italiano di Scienze Mediche Tropicali e di Parassitologia 44: 591-593

Santangelo, U.; Lanzara, A. 1956: Antonio Lanzara. La Riforma Medica 70(15): 435

Caffaratto, T.M. 1959: Antonio Maria Giordano (Piedmontpharmacist). Minerva Farmaceutica 8: 181-186

Yale, S.H.; Valsalva, A.M. 2005: Antonio Maria Valsalva (1666 - 1723). Clinical Medicine and Research 3(1): 35-38

Quesada, F.; Mathijsen, A. 1952: Antonio Mathijsen; Dutch medical officer, inventor of surgical gypsum. Revista de la Sanidad Militar del Peru 25(66): 387-389

Betocchi, G.; Lorenzoni, L.; Mori, A. 1957: Antonio Mori, 1867-1957. Rivista degli infortuni e delle malattie professionali 44(5): 776-782

Shurman, D. 1999: Antonio Provolo: hero or villain?. Journal of Deaf Studies and Deaf Education 4(1): 69

Correa, A.PRUDENTE. 1964: Antonio Prudente Correa, 1915-1964. Revista do Hospital das Clinicas 19: 64-66

Ramos-De la Medina, A. 2005: Antonio Ramos-De la Medina comments made to Uscanga's paper. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 57(1): 98-9; author reply 101

Medea, E.; Rosmini, A. 1963: Antonio Rosmini and medicine. Rassegna di Studi Psichiatrici 52: 221-233

Parigi, G.B.; Scarpa, A. 2004: Antonio Scarpa was an outstanding "head" in the history of surgery. American Journal of Surgery 188(1): 17-21

Masino, C.; Torresano, A. 1963: Antonio Torresano, Apothecary and Bandit of Cuneo in the 16th Century. Minerva Farmaceutica 12: 79-81

Dall'osso, E. 1956: Antonio Vallisnieri to Ippolito Albertini about hasty and badly prepared edition of Malpighi's Consulti of 1713. Il Policlinico. Sezione Pratica 63(37): 1312-1317

Gutierrez Murillo, E.; Benivieni, A.DI.PAOLO. 1956: Antonio di Paolo Benivieni; 1443-1502. La Prensa medica mexicana 21(1): 14-15

Cocchi, G. 2003: Antonio or Federica? a clinical case. Minerva Pediatrica 55(5 Suppl 1: 83-84

Loria, F.L.; Scarpa, A. 1954: Antonio scarpa; anatomist and surgeon. Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 106(7): 269-273

Beerstecher, H.J.; Mathijsen, A. 1964: Antonius Mathijsen. Nederlands Militair Geneeskundig Tijdschrift 17: 118-120

Bloom, V.; Van Leeuwenhoek, A. 1956: Antonj van Leeuwenhoek, man and scientist. Medical Bulletin 22(1): 39-44

Jeandel, R.; Bastien, J.; Antonmarchi, F.; Bonaparte, N.; Rullier 2006: Antonmarchi, last physician of Napoleon: requiem for a forger. Autopsy report published in 1825 is a plagiarism!. Medecine Sciences: M/S 22(4): 434-436

Petit-Dutaillis, D.; Chipault, A. 1952: Antony Chipault 1866-1920. Journal of neurosurgery 9(3): 299-303

Halmai, J.; Leeuwenhoek, A. 1963: Antony Leeuwenhoek. Orvosi Hetilap 104: 1906-1907

Larner, A.J.; Van leeuwenhoel, A. 2005: Antony van Leeuwenhoek and the description of diaphragmatic flutter (respiratory myoclonus). Movement Disorders: Official Journal of the Movement Disorder Society 20(8): 917-918

Shapiro, S.; Van Leeuwenhoek, A. 1955: Antony van Leeuwenhoek; a review of his life and work. Journal of the Biological Photographic Association 23(2-3): 49-57

Stiefelhagen, P.; Dvorák, Aín. 2004: Antonín Dvorák died 100 years ago. A finale in moll. MMW Fortschritte der Medizin 146(16): 68

Brdlik, J.; Mores, A. 1958: Antonín Mores on his 50th birthday. Ceskoslovenska Pediatrie 13(5): 453-455

Horký, K.; Vancura, Aín. 2006: Antonín vancura and arterial hypertension. 50 years' evolution in the conception of pathogenesis and treatment of the disease. Kidney and Blood Pressure Research 29(4): 237-242

Duffau, P.; Morel, D.; Basseau, F.; Merville, P.; Berger, F.; Potaux, L. 2005: Antopol-Goldman lesion: a rare cause of hematuria. Nephrologie and Therapeutique 1(2): 131-134

Scheel-Thomsen, A. 1954: Antoxol therapy of thallium sulfate (zelio) poisoning in dogs and cats. Nordisk Medicin 52(32): 1098-1099

Bagrii, A.K. 1965: Antraglycosides Os some Species of Rumex. Farmatsevtychnyi Zhurnal 20: 54-57

Westerheide, R.L.; Howe, C.T.; Elliott, D.W. 1964: Antral and Pancreatic Stimulation of Gastric Hypersecretion. Surgical Forum 15: 369-371

Johnstone, F.R. 1963: Antral Control of Peptic Secretion. Surgical Forum 14: 345-347

Burge, H. 1964: Antral Dysfunction after Vagotomy and Simple Drainage. Proceedings of the Royal Society of Medicine 57: 396-398

Martinsen, T.C.; Skogaker, N.E.T.; Bendheim, M.Ø.; Waldum, H.L. 2003: Antral G cells in rats during dosing with a PPAR alpha agonist: a morphometric and immunocytochemical study. Medical electron microscopy: official journal of the Clinical Electron Microscopy Society of Japan 36(1): 18-32

Johnston, D.H. 1964: Antral Gastritis: a Biopsy Study of its relation to Duodenal Ulcer and the Ulcer-Like Syndrome. Bulletin of Gastrointestinal Endoscopy 10: 11-14

Diethrich, E.B.; Regan, W.J. 1965: Antral Mucosal Diaphragm Associated with Esophageal Hiatus Hernia; Case Report and Review of the Literature. American Journal of Surgery 110: 482-486

Geffen, A.; Feldman, F. 1961: Antral deformity due to perigastric adhesions or bands simulating carcinoma of the stomach. Radiology 77: 237-247

O'connell, C.D. 1951: Antral disease in relation to the mouth. Irish Journal of Medical Science 302: 79-84

Tihanyi, Z.án.; Luka, F.; Botos, B.áz.; Horváth, L.ás.ó; Szontagh-Kisházi, P.ét.; Altorjay, A. 2005: Antral ectopic pancreas causing gastric outlet obstruction. Magyar Sebeszet 58(5): 331-333

Waddell, W.R.; Bartlett, M.K. 1957: Antral exclusion with vagotomy for duodenal ulcer. I. Acid secretory studies on 50 patients. Annals of Surgery 146(1): 3-11

Gomes, C.A.R.; Catapani, W.R.; Mader, A.M.A.A.; Locatelli, A.; Silva, C.B.- P.; Waisberg, J. 2005: Antral exfoliative cytology for the detection of Helicobacter pylori in the stomach. World Journal of Gastroenterology 11(18): 2784-2788

Elter, K.; Kavak, Z.N.; Gokaslan, H.; Pekin, T. 2005: Antral follicle assessment after down-regulation may be a useful tool for predicting pregnancy loss in in vitro fertilization pregnancies. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 21(1): 33-37

Avril, C. 2006: Antral follicle count and oocyte quality. Journal de Gynecologie Obstetrique et Biologie de la Reproduction 35(5 Part 2): 2s42-2s43

Muttukrishna, S.; McGarrigle, H.; Wakim, R.; Khadum, I.; Ranieri, D.M.; Serhal, P. 2005: Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?. Bjog: An International Journal of Obstetrics and Gynaecology 112(10): 1384-1390

Broekmans, F.J.; Faddy, M.J.; Scheffer, G.; te Velde, E.R. 2004: Antral follicle counts are related to age at natural fertility loss and age at menopause. Menopause 11(6 Part 1): 607-614

Berg, H.M. 1952: Antral gastritis. Radiology 59(3): 324-335

Edlund, Y.; Kjellgren, A.; Stattin, S.; Wickbom, I.; Zettergren, L. 1961: Antral gastritis. a clinical, pathologic, and roentgenographic study of 16 operation cases (partial gastrectomy). Acta Chirurgica Scandinavica 120: 339-346

Castaneda, A.; Griffen, W.O.; Nicoloff, D.; Leonard, A.S.; Wangensteen, O.H. 1960: Antral hyperfunction following portacaval shunt. Surgical Forum 11: 349-351

Gencosmanoglu, R.; Sen-Oran, E.; Kurtkaya-Yapicier, O.; Tozun, N. 2003: Antral hyperplastic polyp causing intermittent gastric outlet obstruction: case report. Bmc Gastroenterology 3: 16

Rollnik, J.D.; Meier, P.N.; Manns, M.P.; Göke, M. 2003: Antral injections of botulinum a toxin for the treatment of obesity. Annals of Internal Medicine 138(4): 359-360

Carruthers, M.O. 1955: Antral intubation and fixation. Journal of Laryngology and Otology 69(7): 498-501

Soltan, M.; Smiler, D.G. 2005: Antral membrane balloon elevation. Journal of Oral Implantology 31(2): 85-90

Bossano Bozzo, M.; Aguiar, A. 1954: Antral mucosal prolapse. Archivos Uruguayos de Medicina Cirugia y Especialidades 44(3-4): 190-216

Pratap, A.; Tiwari, A.; Agrawal, C.S.; Shreshta, P.; Anchal, N.; Shakya, V.C. 2006: Antral mucosal valve: a rare cause of gastric outlet obstruction in newborn. Journal of Pediatric Surgery 41(4): 856-858

Bollobas, B. 1954: Antral perfusion in treatment of otorrhea following mastoidectomy. Magyar Sebeszet 7(2): 150-155

Thierree, R.A.; Laine, P.J. 1961: Antral reactions. Journal de Radiologie d'Electrologie et de Medecine Nucleaire 42: 394-398

Monod, E. 1951: Antral reactions in gastric ulcers. Archives des Maladies de l'Appareil Digestif et des Maladies de la Nutrition 40(3): 362-363

Gutmann, R.A. 1952: Antral region in ulcers of the lesser curvature. Revista Espanola de Las Enfermedades del Aparato Digestivo y de la Nutricion 11(3): 793-814

Brown, C.J.; Allen, R.E. 1957: Antral rhinolith: report of case. Journal of Oral Surgery 15(2): 153-155

Brain, D.J. 1960: Antral rhinolithiasis. Journal of Laryngology and Otology 74: 42-51

Tiao, M.-M.; Ko, S.-F.; Hsieh, C.-S.; Ng, S.-H.; Liang, C.-D.; Sheen-Chen, S.-M.; Chuang, J.-H.; Huang, H.-Y. 2005: Antral web associated with distal antral hypertrophy and prepyloric stenosis mimicking hypertrophic pyloric stenosis. World Journal of Gastroenterology 11(4): 609-611

Xia, H.H.-X.; Lam, S.K.; Wong, W.M.; Hu, W.H.-C.; Lai, K.C.; Wong, S.H.; Leung, S.Y.; Yuen, S.T.; Wright, N.A.; Wong, B.C.-Y. 2003: Antralization at the edge of proximal gastric ulcers: does Helicobacter pylori infection play a role?. World Journal of Gastroenterology 9(6): 1265-1269

Muhlemann, H. 1952: Antraquinon and anthraquinone glucosides. Pharmaceutica Acta Helvetiae 27(1): 17-26

Maur, M. 1963: Antrectomies plus Vagotomies in the Treatment of Gastroduodenal Ulcers. Prensa Medica Argentina 50: 753-754

Palumbo, L.T.; Sharpe, W.S.; Lulu, D.J.; Vespa, R. 1961: Antrectomy with bilateral vagectomy for chronic duodenal ulcer: a new approach eliminating antral and neurogenic functions. Postgraduate Medicine 30: 591-597

Palumbo, L.T.; Sharpe, W.S.; Lulu, D.J.; Vespa, R.; Colonbonet, J. 1959: Antrectomy with vagectomy for chronic duodenal ulcer. Surgery 46: 1005-1011

Palumbo, L.T.; Sharpe, W.S.; Lulu, D.J.; Vespa, R.; Colonbonet, J. 1959: Antrectomy with vagectomy or partial gastrectomy for chronic duodenal ulcer: a comparative analysis. Surgical Clinics of North America 39: 1697-1704

Palumbo, L.T.; Sharpe, W.S.; Lulu, D.J.; Vespa, R.; Colonbonet, J. 1960: Antrectomy with vagectomy or partial gastrectomy with or without vagectomy for chronic duodenal ulcer: a comparative analysis. Annals of Surgery 151: 367-373

Herrington, J.L. 1963: Antrectomy-vagotomy for duodenal ulcer: a fifteen-year appraisal. New York State Journal of Medicine 63: 2489-2493

Calligari, G.; Bottani, G. 1957: Antrenyl as a parasympatholytic in pre-anesthetic medication. Minerva Anestesiologica 23(10): 283-285

Laus, N. 1957: Antrenyl as premedication. El Dia Medico 29(9): 214; Passim

Herzog, H.; Kaufmann, H.; Lang, E.; Speiser, P. 1955: Antrenyl duplex, a new form of peroral administration with depot effect. Schweizerische Medizinische Wochenschrift 85(25): 612-614

Reta, A.G. 1956: Antrenyl in the treatment of duodenal ulcer. Prensa Medica Argentina 43(22): 1779-1784

Weinberg, B.J. 1958: Antrenyl in the treatment of gastrointestinal diseases. American Journal of Gastroenterology 30(6): 630-633

Notkin, L.J. 1955: Antrenyl--a clinical evaluation. Canadian Medical Association Journal 73(7): 535-541

Dodero, M.; Celle, G.; Cheli, R. 1962: Antritis and its relation to phlogosis of the fundus. Biopsy study and anatomo-functional aspects. Minerva Medica 53: 1175-1179

Hill, F.T. 1951: Antro-alveolar fistulae. Transactions of the American Laryngological Rhinological and Otological Society Inc 57(55th Meeting): 1-15

Plante, A. 1952: Antro-nasal odontoblastoma. L'Union Medicale du Canada 81(2): 153-157

Sanches, O.B.; Ferraro, P.; Tarasido, J.C.; Zubizarreta, J. 1961: Antrobuccal fistulas. Considerations on 22 cases. Prensa Medica Argentina 48: 438-440

Freitas, M.R.d.; Giesta, R.ér.P.; Pinheiro, S.ão.D.óg.; Silva, V.C.d. 2006: Antrochoanal polyp: a review of sixteen cases. Brazilian Journal of Otorhinolaryngology 72(6): 831-835

Bertran Escanaverino, R.E.; Basterrechea Zubieta, C.J. 1954: Antrochoanal polypi. Archivos. Hospital Universitario General Calixto Garcia 6(5): 489-496

Gendeh, B.Singh.; Long, Y-Thiam.; Misiran, K. 2004: Antrochoanal polyps: clinical presentation and the role of powered endoscopic polypectomy. Asian Journal of Surgery 27(1): 22-25

Facon, F.; Paris, J.; Dessi, P. 2004: Antrochoanal polyps: diagnosis and management. Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale: Bulletin de la Societe d'Oto-Laryngologie des Hopitaux de Paris 121(6): 315-321

Hsu, Y-Ling.; Kuo, P-Lin.; Cho, C-Yu.; Ni, W-Chiu.; Tzeng, T-Fei.; Ng, L-Teik.; Kuo, Y-Hsiung.; Lin, C-Ching. 2007: Antrodia cinnamomea fruiting bodies extract suppresses the invasive potential of human liver cancer cell line PLC/PRF/5 through inhibition of nuclear factor kappaB pathway. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 45(7): 1249-1257

Nassif, P.A.N.; Fuchs, K.-H.; Heimbucher, J.; Malafaia, O.; Czeczko, N.G.; Ribas Filho, J.M.; Thiede, A.; Dietz, U.A. 2003: Antroduodenal motility and pH changes after partial gastrectomy including the pacemaker region of the dog's stomach. Revista da Associacao Medica Brasileira 49(2): 196-202

Werlin, S.L. 2004: Antroduodenal motility in neurologically handicapped children with feeding intolerance. Bmc Gastroenterology 4: 19

Heimbucher, J.; Fuchs, K.H.; Freys, S.M.; Thiede, A. 1998: Antroduodenal motility in patients with gastroesophageal reflux disease. Langenbecks Archiv für Chirurgie. Suppl. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 115(Suppl I): 89-93

Brown, G.; Scott, R.K.; Holman, W.P.; Wood, I.J.; Finckh, E.S.; Weiden, S.; Davis, P. 1952: Antroduodenectomy and X-ray irradiation in the treatment of duodenal ulcer. Lancet 2(6746): 1145-1149

Brown, G.; Wood, I.J. 1955: Antroduodenectomy and x-ray irradiation in the treatment of duodenal ulcer; a progress report. Australian and New Zealand Journal of Surgery 24(4): 260-267

De Lestrange, M. 1954: Antropologic and pre-hsitoric collections in the Museum of Anthropology. Concours Medical 76(42): 3839-3840

Krmek, N.; Jo-Osvatić, A.; Nikolić, T.; Krmek, V.; Salamon, A. 2006: Antropological measurement of the sacroiliac joint. Collegium Antropologicum 30(4): 811-814

Gullo, A. 1959: Antropometric findings on Palermo children from 6 to 13 years of age (Contribution to the problem of the acceleration of development). Sicilia sanitaria 12: 279-286

Soboczynski, E. 1956: Antropuncture and antrostomy in infants. Otolaryngologia Polska 10(2): 159-162

Helsham, R.W. 1958: Antrostomy with complications. Oral Surgery Oral Medicine and Oral Pathology 11(1): 34-36

Kleitsch, W.P. 1950: Antrotomy for fracture of the malar bone. Plastic and Reconstructive Surgery 5(2): 176-179

Baillon, R. 1963: Antrotomy. Indication for return to present-day practice. Archives Francaises de Pediatrie 20: 125-127

Dragstedt, L.R.; Oberhelman, H.A.; Evans, S.O.; Rigler, S.P. 1954: Antrum hyperfunction and gastric ulcer. Annals of Surgery 140(3): 396-404

Dragstedt, L.R.; Oberhelman, H.A.; Zubiran, J.M.; Woodward, E.R. 1953: Antrum motility as a stimulus for gastric secretion. Gastroenterology 24(1): 71-78

Zacho, A. 1960: Antrum-preserving operation with interposition of jejunum following resection of carcinoma in the upper part of the stomach. Danish Medical Bulletin 7: 132-134

Matos, V.D.'A. 1952: Antrycide methyl sulfate in the campaign against trypanosomiasis in cattle in Lund, Angola. Anais do Instituto de Medicina Tropical 9(3): 843-845

Chauvin, R.; Courtois, G.; Anguenot, F. 1963: Ants (Formica rufa) as possible indicators of radioactive fallout. Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences 256: 508-511

Dollfus, R.P.; Devigne, R. 1965: Ants Responsible for Propagation of the "little Fluke", Dicrocoelium Lanceolatum (Rudolphi, 1803) of Sheep in Lorraine. Observations on Metacercarian Larvae. Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences 260: 1758-1760

Da Costa, S.íl.B.; Pelli, A.; de Carvalho, G.P.; Oliveira, A.G.ça.; da Silva, P.R.; Teixeira, M.M.; Martins, E.; Terra, A.P.S.; Resende, E.M.; da Cunha Hueb Barata de Oliveira, C.; de Morais, C.és.A. 2006: Ants as mechanical vectors of microorganisms in the School Hospital of the Universidade Federal do Triângulo Mineiro. Revista da Sociedade Brasileira de Medicina Tropical 39(6): 527-529

Ferguson, S.E.; Thompson, C.B. 1993: A new break in V(D)J recombination. Current Biology: Cb 3(1): 51-53

Sekera, A.; Rahm, J. 1952: Antural altihelminthic drugs; askaridol. Ceskoslovenska Farmacie 1(8): 471-477

Cubukcu, O.C.; Imre, I.; Onel, D. 1961: Anturan in the gout therapy. Zeitschrift für Rheumaforschung 20: 351-355

Lucey, C. 1961: Anturan in the treatment of gout. Irish Journal of Medical Science 423: 113-121

Levernieux, J. 1960: Anturan on gouty diseases. La Semaine des Hopitaux: Therapeutique 36: 851-853

Scevola, M.E. 1953: Observations on the sterilizing power of an infrared ray oven compared with an electric oven. Il Farmaco; Edizione Pratica 8(11): 574-575

Eychmüller, S.; Felber, S. 2018: Anticipation at the end of life - a critical appraisal for the clinical practice. Therapeutische Umschau. Revue Therapeutique 75(2): 117-122

Balderi, G. 1955: Anular pancreas. Archivio Italiano di Chirurgia 80(5): 385-405

Sulas, V. 1956: Anular pancreas and mongolism in newborn; clinical aspects. Minerva Chirurgica 11(12): 563-565

Schmidt, M.Kruel.; Osvaldt, A.Bersch.; Fraga, Jé.Carlos.Soares.; Takamatu, E.Emy.; Fernandes, C.Lúcia.Szwec.dos.Santos.; Rohde, L. 2004: Anular pancreas--pancreatic resection or duodenal by-pass. Revista da Associacao Medica Brasileira 50(1): 74-78

Antila, L. 1959: Anular pancreas: a case report. Annales Chirurgiae et Gynaecologiae Fenniae 48: 197-202

Acosta, R.; Mesones, R.V.; Núñez, A. 2005: Anuran fauna from Salta city, Argentina. Revista de Biologia Tropical 53(3-4): 569-575

Paraskevas, K.I.; Anagnostou, D.; Bouris, C. 2004: Anurea caused by primary amyloidosis of the lower third of the ureters, the ureterovesical junction and the urinary bladder: a case report and review of the literature. International Urology and Nephrology 36(3): 339-342

Donner, M. 1951: Anuretic diabetic coma. Deutsche Zeitschrift für Verdauungs- und Stoffwechselkrankheiten 11(2-3): 55-63

Labadie, P.; Jaubert, J.L. 1957: Anuria and extrarenal clearance; biological aspects. La Revue du Praticien 7(19): 2112-2119

Kuczynski, J. 1964: Anuria as a Sequel of Bilateral Ligation of Ureters in Cesarean Section. Ginekologia Polska 35: 267-269

Rapin, M.; Amstutz, P.; Gorce, F.; Barois, A.; Goulon, M. 1964: Anuria Caused by Acute Interstitial Nephropathy in the Course of Prolonged Phenindione Treatment. La Presse Medicale 72: 2279-2284

Heully, F.; Larcan, A.; Rauber, G.; Huriet, C.; Vaillant, G.; Aug, M.C. 1963: Anuria Caused by Carbon Tetrachloride Poisoning. Apropos of 5 Cases. Annales Medicales de Nancy 2: 1184-1195

Schilliro, R.; Bezombes 1965: Anuria Due to Cystopathy. Journal d'Urologie et de Nephrologie 71: 118-119

Conolly, M.E.; Ellis, H. 1964: Anuria Due to Uric Acid Crystalluria: An Unusual Complication of Therapy in the Reticuloses. British journal of cancer 18: 247-251

Warembourg, H.; Niquet, G.; Ducloux, G.; Stalnikiewicz, G.; Perrard, C.; Bertrand, M. 1964: Anuria from Absorption of Massive Doses of Isoniazide. Artificial Kidney. Recovery. Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 9: 837-843

Gayer, J. 1965: Anuria in Bilateral Ureteral Stenosis Due to Uterine Cancer. Die Medizinische Welt 18: 213-214

Weissel, W.; Brechelmacher, G.; Hammerl, H.; Zimmermann, E. 1964: Anuria in Plasmocytoma Kidney. Wiener Zeitschrift für Innere Medizin und ihre Grenzgebiete 45: 73-79

Sigel, A. 1965: Anuria in Prostatic Cancer. Analysis of 100 Cases. Zeitschrift für Urologie 58: 1-9

Pirontidicampagna, G.M.; Iannello, P. 1963: Anuria Subsequent to Retrograde Pyelography with Bilateral Reflux. Annali Italiani di Chirurgia 40: 653-658

Knebelmann, G.; Lavaurs, G. 1961: Anuria after aortography. Cure with artificial kidney. Journal d'Urologie et de Nephrologie 67: 546-547

Dutour, G.; Nebout; Poutier 1955: Anuria after jennerian vaccination. Bulletins et Memoires de la Societe Medicale des Hopitaux de Paris 71(29-31): 1127-1129

Hindberg, J.; Nakamoto, S.; Kolff, W.J. 1961: Anuria after operation for abdominal aortic aneurysm treated by hemodialysis with complete recovery. Surgery 50: 755-757

Lindholm, T. 1958: Anuria after or caused by obstetrical collapse treated with a nepresol-hibernalpethidine preparation. Svenska Lakartidningen 55(22): 1628-1630

Szendi, B. 1953: Anuria after surgery of irradiated recidivating giant cancer of the uterus. Zentralblatt für Gynakologie 75(38): 1492-1495

Sautot, J.; Traeger, J. 1962: Anuria after thrombo-endarteriectomy of the abdominal aorta. Renal epuration. Recovery. Remote result (4 years). Memoires. Academie de Chirurgie 88: 577-584

Bull, G.M. 1958: Anuria and its management. Practitioner 181(1083): 262-270

Chuchelov, N.I. 1955: Anuria and oliguria following labor and abortion. Urologiia 1: 22-24

Hopper, J.J.; Partridge, J.W. 1950: Anuria and oliguria; treatment by conservative means, case report, with determination of blood volume and Na24 space. California Medicine 73(1): 42-53

Joekes, A.M. 1950: Anuria and the surgeon. British Journal of Urology 22(2): 125-131

Loebenstein, H. 1950: Anuria and uremia due to sulfonamide intoxication. Wiener Klinische Wochenschrift 62(30): 525-527

Abramoff, A. 1962: Anuria as a complication in myeloid leukemia. Harefuah 63: 212-214

Geissendorfer, R. 1957: Anuria as a complication of surgical diseases. Langenbecks Archiv für Klinische Chirurgie . Vereinigt Mit Deutsche Zeitschrift für Chirurgie 287: 562-579

Letterer, E. 1957: Anuria as a complication of surgical diseases; anatomopathological report. Langenbecks Archiv für Klinische Chirurgie .. Vereinigt Mit Deutsche Zeitschrift für Chirurgie 287: 549-561

Post, J. 1961: Anuria as a presenting symptom in unsuspected leukemia. New England Journal of Medicine 264: 1253-1254

Dohnicht, A. 1958: Anuria as a sequel to a bland right stone obstruction in levolateral ureteral stricture. Die Medizinische 3(22): 919-921

Martorell, F.; Sanchez-Harguindey, L. 1960: Anuria as cause of death in ascending aortoiliac thrombosis. Angiologia 12: 206-209

Carre, I.J.; Squire, J.R. 1956: Anuria ascribed to acute tubular necrosis in infancy and early childhood. Archives of Disease in Childhood 31(160): 512-522

Manoil, L. 1962: Anuria associated with severe gallbladder disease attack. Arizona Medicine 19: 40-42

Ezes, H. 1952: Anuria at the ninth month of pregnancy; recovery by cesarean section after failure of medical treatment. Bulletin de la Federation des Societes de Gynecologie et Dobstetrique de Langue Francaise 4(2): 352-353

Ruol, A.; D'agnolo, B.; Piccolo, E. 1957: Anuria caused by aortography. Acta Medica Patavina 17(1): 49-66

Johnson, N. 1954: Anuria caused by blood-clot obstruction of a solitary ureter. Australian and New Zealand Journal of Surgery 24(1): 76-77

Nociti, V. 1954: Anuria caused by burns and related renal histopathology. Minerva Chirurgica 9(20): 922-936

Richet, G.; Crosnier, J.; Lissac, J. 1959: Anuria caused by carbon tetrachloride poisoning; 25 case reports. La Revue du Praticien 9(6): 591

Patoir, G.; Bedrine, H. 1957: Anuria caused by edematous ureteritis following the Wertheim operation. Bulletin de la Federation des Societes de Gynecologie et Dobstetrique de Langue Francaise 9(5): 573-575

Hamburger, J. 1958: Anuria caused by inhalation of carbon tetrachloride. Acquisitions Medicales Recentes 1958: 15-34

Otsetov, K. 1957: Anuria caused by lithiasis of upper urinary tract. Khirurgiia 10(7): 649-655

Rada, Z. 1950: Anuria caused by nephrolithiasis in solitary kidney. Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 29(10): 410-413

Soto, R.; Gordillo, G.; Gil Mota, C.; Uribe, F.; De Castaneda J, J. 1958: Anuria caused by obstruction of the upper urinary tract. Boletin Medico del Hospital Infantil de Mexico 15(5): 703-713

Oka, N.; Tsukamoto, T.; Kato, T. 1963: Anuria caused by pressure on the bladder. Report on 5 cases. Therapy 45: 1451-1457

Nicol, M. 1955: Anuria caused by sulfonamides. Bordeaux Chirurgical 3: 165-167

Shramko, N.P.; Rybinnik, I.M. 1958: Anuria caused by thrombosis of the renal artery. Urologiia 23(5): 62-63

De Keyzer, R. 1954: Anuria caused by unilateral obstruction in aplasia of the contralateral kidney. Belgisch Tijdschrift Voor Geneeskunde 10(24): 1171-1173

Sohn, A. 1952: Anuria caused by ureteral calculi in congenital solitary kidney. Zentralblatt für Chirurgie 77(45): 2248-2251

Shmukler, B.A. 1958: Anuria caused by ureterocele. Urologiia 23(5): 63-65

Rotellar, E. 1959: Anuria caused by vaginal absorption of potassium permanganate treated with an artificial kidney. Revista Clinica Espanola 74: 38-39

Kritzler, R.A. 1958: Anuria complicating the treatment of leukemia. American Journal of Medicine 25(4): 532-538

Zakynthinos, E.; Douka, E.; Daniil, Z.; Konstantinidis, K.; Markaki, V.; Zakynthinos, S. 2005: Anuria due to acute bilateral renal vein occlusion after thrombolysis for pulmonary embolism. International Journal of Cardiology 101(1): 163-166

Salmoni, R. 1950: Anuria due to acute diffuse glomerulonephritis treated with anesthetic infiltration of the renal peduncle. Accademia Medica 65(7): 265-268

Chiriboga Ledesma, M. 1950: Anuria due to acute mercurial poisoning; treatment with an isotonic solution of sodium sulfate. Revista Clinica Espanola 39(5): 345-346

O'brien, D. 1959: Anuria due to bismuth thioglycollate. A.M.A. Journal of Diseases of Children 97(4): 384-386

Zabludovich, S.; Milman, F. 1958: Anuria due to phenylbutazone. Prensa Medica Argentina 45(37): 3035-3036

Thalheimer, M.; Derot, M. 1951: Anuria due to toxi-infectious hepatonephritis. Memoires. Academie de Chirurgie 77(1-3): 49-54

Gómez Dammeier, B.H.; Karanik, E.; Glüer, S.; Jesch, N.K.; Kübler, J.; Latta, K.; Sümpelmann, R.; Ure, B.M. 2005: Anuria during pneumoperitoneum in infants and children: a prospective study. Journal of Pediatric Surgery 40(9): 1454-1458

Seear-Jensen, T. 1950: Anuria following a single subcutaneous dose of sulfathiazole. Ugeskrift for Laeger 112(9): 307-308

Hjertaas, A. 1952: Anuria following carbaminoylcholine chloride. Nordisk Medicin 47(12): 403

Bitschai 1950: Anuria following ingestion of a poisonous plant. Journal d'Urologie Medicale et Chirurgicale 56(10): 817

Zilberg, B. 1958: Anuria following penicillin administration. South African Medical Journal 32(13): 350-352

Weisman, J.I.; Bloom, B. 1955: Anuria following phenylbutazone therapy. New England Journal of Medicine 252(25): 1086-1087

Lear, H.; Oppenheimer, G.D. 1950: Anuria following radiation therapy in leukemia. Journal of the American Medical Association 143(9): 806-807

Frank, H. 1952: Anuria following therapeutic use of sulfonamides. Zeitschrift für Arztliche Fortbildung 46(18): 538-540

Davison, J.C.; McDANIEL, W.H. 1950: Anuria following treatment with a multiple sulfonamide preparation. Ulster Medical Journal 19(2): 176-177

Coufal, J. 1960: Anuria following unilateral ascendent pyelography during sudden failure of the adrenals. Acta Tuberculosea Scandinavica 39: 161-164

Coufal, J. 1959: Anuria following unilateral ascending pyelography in a sudden adrenal insufficiency. Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 38: 716-718

Duvergey, H.; Verger, P.; Dupuy, P. 1951: Anuria in a 16 month-old infant; calculi of pure cystine at the level of the upper urinary tract on both sides. Journal d'Urologie Medicale et Chirurgicale 57(1-2): 88-91

Gayet, R.; Planson, E.; Bailly, A. 1953: Anuria in a newborn infant with urethral obliteration. Journal d'Urologie Medicale et Chirurgicale 59(12): 917-919

Nabarro, J.D.N.; Spencer, A.F. 1951: Anuria in acute nephritis. British Medical Journal 2(4728): 393-397

Vicchi, M.F.; Abela Deheza, C. 1953: Anuria in an infant and its relation to chloromycetin therapy. Revista Argentina de Urologia 22(7-8): 222-228

Stajic, S. 1950: Anuria in children. Srpski Arhiv Za Celokupno Lekarstvo 48(3): 240-243

Vallery-Radot, P.; Milliez, P.; Laroche, C.; Funck-Brentano, J.L. 1955: Anuria in chronic nephritis. La Presse Medicale 63(80): 1663-1664

Rao, K.B. 1957: Anuria in concealed accidental haemorrhage. Journal of the Indian Medical Association 29(10): 392-399

Richards, R.L.; Gibson, J.B. 1953: Anuria in nephritis: report of a case. Glasgow Medical Journal 34(3): 126-130

Von Mikulicz-Radecki, F. 1954: Anuria in obstetric and gynecological diseases. Munchener Medizinische Wochenschrift 96(43): 1247

Gill, R.C. 1951: Anuria in obstetric practice. Medical Journal of Australia 2(2): 45-47

Lowe, K.G. 1960: Anuria in patients with single functioning kidney. British Journal of Urology 32: 267-268

Ciminata, A. 1956: Anuria in surgery. Il Policlinico. Sezione Pratica 63(50): 1789-1792discussion: 1792-1794

Ciminata, A. 1956: Anuria in surgery: study of pathogenesis and therapy. La Riforma Medica 70(48): 1379-1383; Discussion: 1383-1386

Cantarovich, F. 1963: Anuria in the aged. Revista de la Asociacion Medica Argentina 77: 134-136

Mozziconacci, P.; Royer, P.; Lagrue, G. 1957: Anuria in the child. Gazette Medicale de France 64(1): 15-16 Passim

Krzeski, T. 1954: Anuria in urinary lithiasis. Polski Tygodnik Lekarski 9(5): 142-147

Bernardi, R.; Budich, M. 1950: Anuria of 48 hours duration from cancer of the prostate treated with estrogens. Revista Argentina de Urologia 19(9-12): 180

Michon, P.; Larcan, A.; Huriet, C.; Vicari, F. 1962: Anuria of complex cause: right renal tuberculosis and embolism of the left renal artery. La Presse Medicale 70: 718

Goetz, R.H.; Selmonosky, C.A.; State, D. 1961: Anuria of hypovolemic shock relieved by tris (hydroxymethyl) aminomethane (THAM). Surgery Gynecology and Obstetrics 112: 724-728

Merger, R.; Crosnier, J.; Levy, J.; Melchior, J.; Martin, J. 1953: Anuria of pregnancy. Gynecologie et Obstetrique 52(3): 266-278

Biorn, C.L. 1952: Anuria owing to urethral obstruction by sulfadiazine crystals. California Medicine 77(3): 196-197

Caissel, J. 1952: Anuria post abortum treated by distension of the kidney pelvis with xylocaine solution and high doses of sterandryl. Journal d'Urologie Medicale et Chirurgicale 58(3-4): 208-209

Derot, M.; Touraine, R.; Bernard, J.; Thin, G. 1952: Anuria post abortum with contractures resembling splanchnic tetanus; probable role of hyperpotassemia. Bulletins et Memoires de la Societe Medicale des Hopitaux de Paris 68(32-33): 1236-1239

Pearlman, C.K.; Mackey, J.F. 1960: Anuria resulting from abdominal aneurysm. Journal of Urology 83: 184-187

Adney, F.B.; Waller, J.I. 1950: Anuria resulting from sulfonamide therapy. Journal of the Indiana State Medical Association 43(11): 1085-1088

Duncan, D.A.; Dexter, R.N. 1962: Anuria secondary to bilateral renal-artery embolism. New England Journal of Medicine 266: 971-973

Al-Tawheed, A.R.; Al-Awadi, K.A.; Kehinde, E.O.; Abdul-Halim, H.; Al-Hunayan, A.; Ali, Y.; Mohammed, A.H. 2003: Anuria secondary to hot weather-induced hyperuricaemia: diagnosis and management. Annals of Saudi Medicine 23(5): 283-287

Jeanbrau; Truc; Laval 1951: Anuria therapy. Concours Medical 73(6): 481-487

Moore, H.; O'donovan, D.K. 1953: Anuria treated by cortisone. British Medical Journal 1(4803): 183-188

Moore, H.F. 1952: Anuria treated with cortisone. Irish Journal of Medical Science 319: 298-299

Klingelhoffer, F.; Lucius, G.F. 1959: Anuria with dissecting aneurysm. Zeitschrift für Urologie 52(1): 68-72

Wermut, W. 1960: Anuria ws a sequel of chronic renal diseases. Polski Tygodnik Lekarski 15: 841-844

Takayasu, H. 1963: Anuria, Dysuria. NAIKA. Internal Medicine 12: 852-855

Yoshitoshi, Y.; Sanjo, T. 1964: Anuria, Retention of Urine. NAIKA. Internal Medicine 13: 893-898

Verriere, M. 1952: Anuria, functional or psychosomatic origin. Journal d'Urologie Medicale et Chirurgicale 58(3-4): 159-163

Gausa Rull, P. 1958: Anuria. Current views on its treatment. Archivos Espanoles de Urologia 14: 202-209

Silver, G.B. 1954: Anuria: case report; diagnostic and therapeutic problems. Connecticut State Medical Journal 18(8): 657-661

Levy, M.; Sapir, M.; Ranaud, S.; Tichit, L. 1952: Anuria: importance of electrolyte balance. Journal d'Urologie Medicale et Chirurgicale 58(5): 282-308

Kirwin, T.J. 1950: Anuria: its treatment by various methods, including the artificial kidney. Transactions. American Urological Association. Western Section 17: 25-49

Hunter, A.A.; Read, J.R. 1954: Anuria: report of a case, with discussion of therapy. Medical Journal of Australia 41(1 12): 433-438

Shapiro, I.N. 1955: Anuria; classification, pathogenesis, therapy. Urologiia 1: 14-22

Duhamel, M. 1962: Anurias. Journal des Sciences Medicales de Lille 80: 193-201

Alcala Santaella, R. 1951: Anurias and their modern therapy. Medicina Espanola 25(142): 1-21

Aboulker, P.; Derot, M. 1957: Anurias following prostatectomy. Gazette Medicale de France 64(8): 773-774

Charvet, F. 1960: Anurias of obstetrical origin. Revue Francaise de Gynecologie et d'Obstetrique 55: 421-432

Warter, J.; Mantz, J.M.; Batzenschlager, A.; Maurer, M. 1960: Anurias revealing Kahler's disease. Strasbourg Medical 11: 418-428

Lockhart, J. 1953: Anurias; etiology and pathogenesis. Anales de la Facultad de Medicina Universidad de la Republica Montevideo Uruguay 38(3-4): 105-134

Mosqueira, M.S.; Maggiolo, L. 1951: Anurias; management. El Dia Medico 23(26): 1052-1060

Derot, M.; Roy, J.L. 1960: Anuric acute glomerulonephritis revealing acute articular rheumatism. Bulletins et Memoires de la Societe Medicale des Hopitaux de Paris 76: 856-859

López-Menchero, R.; Albero, M.D.; Barrachina, M.D.; Alvarez, L. 2006: Anuric acute renal failure due to acetazolamide. Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 26(6): 755-756

Marcel, J.E.; Derome, M.; Cacolyris, T.; Roudier, R. 1960: Anuric hematuric nephropathy in an infant: exchange transfusion; punch biopsy of the kidney. Recovery. Journal d'Urologie Medicale et Chirurgicale 66: 184-193

Derot, M.; Bernard, J.; Touraine, R.L. 1953: Anuric nephropathies with fatal evolution. Gazette Medicale de France 60(3): 183-188

Derot, M.; Pignard, P.; Miocque, M. 1954: Anuric tubular nephropathy; attacks of tetany and decalvant alopecia during convalescence. Bulletins et Memoires de la Societe Medicale des Hopitaux de Paris 70(9-10): 319-325

Reyes, Z.S.; Bataclan, F.A.; Nair, P.M.C.; Sankhla, D.K. 2004: Anuric unless catheterized. Saudi Medical Journal 25(10): 1503

Leong, W.-S.; Sells, H.; Moretti, K.L. 2004: Anuric, obstructive uropathy in the absence of obvious radiological evidence of obstruction. ANZ Journal of Surgery 74(7): 611-613

Bagdány, M.ós.; Batista, C.V.F.; Valdez-Cruz, N.A.; Somodi, S.án.; Rodriguez de la Vega, R.C.; Licea, A.F.; Varga, Z.án.; Gáspár, R.; Possani, L.D.; Panyi, G.ör. 2005: Anuroctoxin, a new scorpion toxin of the alpha-KTx 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes. Molecular Pharmacology 67(4): 1034-1044

Ceulemans, G. 1964: Anus Praeternaturalis. Tijdschrift Voor Gastro-Enterologie 7: 290-294

Harris, J.K. 1961: Anus and rectum. Pediatric Clinics of North America 8: 151-156

Goetze, O. 1950: Anus praeter peniformis. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 21(3): 153-160

Weis, J. 1950: Anus vaginalis in a sow. Casopis Ceskoslovenskych Veterinaru 5(6): 136-137

Shafik, A. 2004: Anus-preserving operation for low rectal and anal canal cancers. Techniques in Coloproctology 8(1): 56; Author Reply 56

Perry, G.G. 1960: Anusitis. Southern Medical Journal 53: 953-956

Euler, H.E. 1962: Anvil stump prosthesis with supramid foil in stapes surgery. Hno 10: 57-58

Srivastava, M.; Eidelman, O.; Leighton, X.; Glasman, M.; Goping, G.; Pollard, H.B. 2002: Anx7 is required for nutritional control of gene expression in mouse pancreatic islets of Langerhans. Molecular Medicine 8(12): 781-797

Wiebe, E.R.; Trouton, K.J.; Fielding, S.L.; Grant, H.; Henderson, A. 2004: Anxieties and attitudes towards abortion in women presenting for medical and surgical abortions. Journal of Obstetrics and Gynaecology Canada: Jogc 26(10): 881-885

Pellerin, J. 2006: Anxieties and refusal to eat. L'Encephale 32 Pt 4: S1147-S1148

Mitchell, H.E.; Mudd, E.H. 1957: Anxieties associated with the conduct of research in a clinical setting. American Journal of Orthopsychiatry 27(2): 310

Trimble, M. 2001: Anxieties over the diagnostic and statistical manual of mental disorders. Cns Spectrums 6(11): 890

Williams, G.L.; Clarke, P.; Vellacott, K.D. 2006: Anxieties should not be forgotten when screening relatives of colorectal cancer patients by colonoscopy. Colorectal Disease: the Official Journal of the Association of Coloproctology of Great Britain and Ireland 8(9): 781-784

Bound, F. 2004: Anxiety. Lancet 363(9418): 1407

Seabra-Dinis, J. 1958: Anxiety and neuroses. Jornal do Medico 37(819): 169-171 Passim

Menninger, W.C. 1959: Anxiety and tension of modern life. Medicina 39(821): 249-251

Blau, A.; Hulse, W.C. 1956: Anxiety ("actual") neuroses as a cause in behavior disorders in children. American Journal of Orthopsychiatry 26(1): 108-114

Friend, M.R. 1956: Anxiety ("actual") neuroses as a cause of behavior disorders in children. American Journal of Orthopsychiatry 26(1): 114-118

Harris, J.C.; Munch, E. 2004: Anxiety (Angst). Archives of General Psychiatry 61(1): 15-16

Spence, K.W. 1964: Anxiety (Drive) Level and Performance in Eyelid Conditioning. Psychological Bulletin 61: 129-139

Flescher, I. 1963: Anxiety and Achievement of Intellectually Gifted and Creatively Gifted Children. Journal of Psychology 56: 251-268

Suinn, R.M. 1965: Anxiety and Cognitive Dissonance. Journal of General Psychology 73: 113-116

Ernst, E.M. 1963: Anxiety and Depression: Treatment in General Practice. Pennsylvania Medical Journal 66: 43-45

Distler, L.S.; May, P.R.; Tuma, A.H. 1964: Anxiety and Ego Strength as Predictors of Response to Treatment in Schizophrenic Patients. Journal of Consulting Psychology 28: 170-177

Basaglia, F. 1964: Anxiety and Insincerity: the Human Condition of the Neurotic. Rivista Sperimentale di Freniatria e Medicina Legale Delle Alienazioni Mentali 88: 392-404

Pont, M.; Chapuy, A.; Vedrinne, J. 1964: Anxiety and Insomnia. Apropos of a new Medicamentous Combination: le Fh 040-3. Lyon Medical 211: 465-469

Suinn, R.M. 1965: Anxiety and Intellectual Performance: a Partial Failure to Replicate. Journal of Consulting Psychology 29: 81-82

Lopez Ibor, J. 1965: Anxiety and its Treatment. Munchener Medizinische Wochenschrift 107: 696-700

Brod, D.; Kernoff, P.; Terwilliger, R.F. 1964: Anxiety and Semantic Differential Responses. Journal of Abnormal Psychology 68: 570-574

Spivack, G.; Levine, M.; Graziano, A. 1964: Anxiety and Set in the Rorschach test. Journal of Consulting Psychology 28: 189

Annis, E.R. 1964: Anxiety and the Health Professions. Journal of Neuropsychiatry 5: 429-431

Walter, D.; Denzler, L.S.; Sarason, I.G. 1964: Anxiety and the Intellectual Performance of high School Students. Child Development 35: 917-926

Brody, N. 1964: Anxiety and the Variability of Work Associates. Journal of Abnormal Psychology 68: 331-334

Denike, L.D.; Stein, L.S. 1965: Anxiety and Verbal Conditioning. Journal of Personality and Social Psychology 1: 229-239

Thomstad, H.; Aas, K. 1964: Anxiety as a Symptom. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 84: 258-264

Bonaccorsi, M.T. 1965: Anxiety during the Course of Psychiatric Training. Canadian Psychiatric Association Journal 10: 188-193

Jackson, L. 1964: Anxiety in Adolescents in Relation to School Refusal. Journal of Child Psychology and Psychiatry and Allied Disciplines 5: 59-73

Routh, T.A. 1963: Anxiety in Clinical Diagnosis. Minerva Medica 54: 2507-2511

Noguer More, S.; Noguer Debray, S. 1963: Anxiety in Progressive Alopecias. Possibilities for Neuropsychic Drugs. Actas Dermo-Sifiliograficas 54: 349-351

Armilla, J. 1964: Anxiety in Taking the Role of the Leader. Journal of Abnormal Psychology 68: 550-552

Strank, R.A. 1965: Anxiety Neurosis Complicated by Addiction to Sodium Amytal. Nursing Times 61: 792-793

Vella, G. 1964: Anxiety States. Aggiornamenti Clinicoterapeutici 5: 1-48

Lapiccirella, V. 1963: Anxiety States, Respiratory Dysrhythmia, with Slight Chronic Anoxia in the Pathogenesis of Solitary Pulmonary Hypertension. Cardiologia Pratica 14: 215-226

Willows, N.D.; Iserhoff, R.; Napash, L.; Leclerc, L.; Verrall, T. 2005: Anxiety about food supply in cree women with infants in Quebec. International Journal of Circumpolar Health 64(1): 55-64

Levine, G.N. 1962: Anxiety about illness: psychological and social bases. Journal of Health and Human Behavior 3: 30-34

Bolanowski, W. 2005: Anxiety about professional future among young doctors. International Journal of Occupational Medicine and Environmental Health 18(4): 367-374

Beukenkamp, C. 1959: Anxiety activated by the idea of marriage as observed in group psychotherapy. Mental Hygiene 43: 532-538

Monzani, D.; Marchioni, D.; Bonetti, S.; Pellacani, P.; Casolari, L.; Rigatelli, M.; Presutti, L. 2004: Anxiety affects vestibulospinal function of labyrinthine-defective patients during horizontal optokinetic stimulation. Acta Otorhinolaryngologica Italica: Organo Ufficiale Della Societa Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale 24(3): 117-124

Freeman, T.; Cameron, J.L. 1953: Anxiety after electroshock therapy in involutional melancholia. British Journal of Medical Psychology 26(3-4): 245-261

Brier, N. 2004: Anxiety after miscarriage: a review of the empirical literature and implications for clinical practice. Birth 31(2): 138-142

Robie, T.R. 1960: Anxiety amelioration, a dual approach. Diseases of the Nervous System 21: 588-590

Britt, D.W.; Risinger, S.T.; Mans, M.; Evans, M.I. 2003: Anxiety among women who have undergone fertility therapy and who are considering multifetal pregnancy reduction: trends and implications. Journal of Maternal-Fetal and Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine the Federation of Asia and Oceania Perinatal Societies the International Society of Perinatal Obstetricians 13(4): 271-278

Moroni, L.; Bettinardi, O.; Vidotto, G.; Balestroni, G.; Bruletti, G.; Giorgi, I.; Bertolotti, G. 2006: Anxiety and Depression Short Scale: norms for its use in rehabilitation. Monaldi Archives for Chest Disease 66(4): 255-263

Ballenger, J.C.. 2000: Anxiety and Depression: Optimizing Treatments. Primary Care Companion to the Journal of Clinical Psychiatry 2(3): 71-79

Pasche, F. 1954: Anxiety and Freudian theory of instincts. Revue Francaise de Psychanalyse 18(1): 76

Nutt, D.; Malizia, A. 2006: Anxiety and OCD - the chicken or the egg?. Journal of Psychopharmacology 20(6): 729-731

Trent, R.D. 1959: Anxiety and accuracy of perception of sociometric status among institutionalized delinquent boys. Journal of Genetic Psychology 94(1): 85-91

Boulenger, J.-P.; Piquet, C.éc.; Hermès, A.; Aussilloux, C. 2003: Anxiety and adjustment disorders. La Revue du Praticien 53(15): 1715-1722

Michel-Lauriat, H. 1952: Anxiety and aggression in children. Maroc Medical 31(327): 674-679

Pasqui, E. 1952: Anxiety and aggressiveness on the Rorschach test. Rivista di Neurologia 22(5): 659-671

Porta, V. 1959: Anxiety and angulsh in life and in psychiatry today. Rassegna di Neuropsichiatria E Scienze Affini 13: 179-189

Zethraeus, S.; Dencker, S. 1952: Anxiety and attacks of anxiety. Svenska Lakartidningen 49(47): 2884-2892

Antoni, N. 1953: Anxiety and attacks of anxiety, with reference to an article by Stig Zetraeus and Sven Dencker in no. 47. Svenska Lakartidningen 50(1): 1-7